{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:18:28Z","timestamp":1794352708237,"version":"4.9.0"},"reference-count":376,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chongqing Medical Youth Top Talent Program","award":["YXQN202558"],"award-info":[{"award-number":["YXQN202558"]}]},{"name":"Chongqing Youth Innovation Talent Project","award":["CSTB2025YITP-QCRCX0096"],"award-info":[{"award-number":["CSTB2025YITP-QCRCX0096"]}]},{"name":"Science Foundation of the AMHT Group","award":["2022YK04"],"award-info":[{"award-number":["2022YK04"]}]},{"name":"Key R&D Program of Jiangxi Province","award":["20243BBI91007"],"award-info":[{"award-number":["20243BBI91007"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372943, 82303610, 82503442"],"award-info":[{"award-number":["82372943, 82303610, 82503442"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Science and Technology Innovation Program of Hunan Province","award":["2023RC3074"],"award-info":[{"award-number":["2023RC3074"]}]},{"name":"Jiangxi Provincial Health Technology Project","award":["202510008"],"award-info":[{"award-number":["202510008"]}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"crossref","award":["Y-Gilead2024-PT-0070"],"award-info":[{"award-number":["Y-Gilead2024-PT-0070"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["20252BAC220048"],"award-info":[{"award-number":["20252BAC220048"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02666-x","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:59:31Z","timestamp":1778054371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Non-coding RNAs as master regulators of ferroptosis in cancer: mechanisms and clinical implications"],"prefix":"10.1186","volume":"25","author":[{"given":"Haoyang","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wantao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"2666_CR1","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death. Cell . 2012;149:1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042. [cited 2025 Nov 24];","journal-title":"Cell"},{"key":"2666_CR2","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","volume":"21","author":"S Bedoui","year":"2020","unstructured":"Bedoui S, Herold MJ, Strasser A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol . 2020;21:678\u201395. https:\/\/doi.org\/10.1038\/s41580-020-0270-8. [cited 2025 Nov 24].","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2666_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, et al. Ferroptosis: process and function. Cell Death Differ . 2016;23:369\u201379. https:\/\/doi.org\/10.1038\/cdd.2015.158. [cited 2025 Nov 24].","journal-title":"Cell Death Differ"},{"key":"2666_CR4","doi-asserted-by":"publisher","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17:2054\u201381. https:\/\/doi.org\/10.1080\/15548627.2020.1810918.\u00a0Cited 24 Nov 2025.","DOI":"10.1080\/15548627.2020.1810918"},{"key":"2666_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1416","volume":"10","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 2014;10:9\u201317. https:\/\/doi.org\/10.1038\/nchembio.1416. [cited 2025 Nov 24].","journal-title":"Nat Chem Biol"},{"key":"2666_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin H, Huang Z, Lin Z, Mao N, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11:88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2. [cited 2025 Nov 24].","journal-title":"Cell Death Dis"},{"key":"2666_CR7","doi-asserted-by":"publisher","unstructured":"Sun L, Dong H, Zhang W, Wang N, Ni N, Bai X, et al. Lipid peroxidation, depletion GSH and SLC7A11 inhibition are common causes of EMT and ferroptosis in A549 cells, but different in specific mechanisms. DNA and Cell Biology. 2021;40:172\u201383. https:\/\/doi.org\/10.1089\/dna.2020.5730.\u00a0Cited 24 Nov 2025.","DOI":"10.1089\/dna.2020.5730"},{"key":"2666_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fphar.2020.00239","volume":"11","author":"C Han","year":"2020","unstructured":"Han C, Liu Y, Dai R, Ismail N, Su W, Li B. Ferroptosis and Its Potential Role in Human Diseases. Front Pharmacol. 2020;11:239. https:\/\/doi.org\/10.3389\/fphar.2020.00239. [cited 2025 Nov 24].","journal-title":"Front Pharmacol"},{"key":"2666_CR9","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nat. 2019;575:688\u201392. https:\/\/doi.org\/10.1038\/s41586-019-1705-2. [cited 2025 Nov 24].","journal-title":"Nat"},{"key":"2666_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"VAN Kraft","year":"2020","unstructured":"Kraft VAN, Bezjian CT, Pfeiffer S, Ringelstetter L, M\u00fcller C, Zandkarimi F, et al. GTP Cyclohydrolase 1\/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling. ACS Cent Sci. 2020;6:41\u201353. https:\/\/doi.org\/10.1021\/acscentsci.9b01063. [cited 2025 Nov 24].","journal-title":"ACS Cent Sci"},{"key":"2666_CR11","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","volume":"16","author":"M Soula","year":"2020","unstructured":"Soula M, Weber RA, Zilka O, Alwaseem H, La K, Yen F, et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat Chem Biol. 2020;16:1351\u201360. https:\/\/doi.org\/10.1038\/s41589-020-0613-y. [cited 2025 Nov 24].","journal-title":"Nat Chem Biol"},{"key":"2666_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18:280\u201396. https:\/\/doi.org\/10.1038\/s41571-020-00462-0. [cited 2025 Nov 24].","journal-title":"Nat Rev Clin Oncol"},{"key":"2666_CR13","doi-asserted-by":"publisher","unstructured":"Wang Y, Wei Z, Pan K, Li J, Chen Q. The function and mechanism of ferroptosis in cancer. Apoptosis. 2020;25:786\u201398. https:\/\/doi.org\/10.1007\/s10495-020-01638-w.\u00a0Cited 24 Nov 2025.","DOI":"10.1007\/s10495-020-01638-w"},{"key":"2666_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. 2017;171:273\u201385. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021. [cited 2025 Nov 24].","journal-title":"Cell"},{"key":"2666_CR15","doi-asserted-by":"publisher","unstructured":"Stockwell BR, Jiang X. A Physiological Function for Ferroptosis in Tumor Suppression by the Immune System. Cell Metabolism. 2019;30:14\u20135. https:\/\/doi.org\/10.1016\/j.cmet.2019.06.012.\u00a0\u00a0Cited 24\u00a0Nov 2025.","DOI":"10.1016\/j.cmet.2019.06.012"},{"key":"2666_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gij\u00f3n M, Kennedy PD, Johnson JK, et al. CD8\u2009+\u2009T cells regulate tumour ferroptosis during cancer immunotherapy. Nat. 2019;569:270\u20134. https:\/\/doi.org\/10.1038\/s41586-019-1170-y. [cited 2025 Nov 24].","journal-title":"Nat"},{"key":"2666_CR17","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting Ferroptosis to Iron Out Cancer. Cancer Cell. 2019;35:830\u201349. https:\/\/doi.org\/10.1016\/j.ccell.2019.04.002. [cited 2025 Nov 24].","journal-title":"Cancer Cell"},{"key":"2666_CR18","doi-asserted-by":"publisher","unstructured":"Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M et al. Pharmacological inhibition of cystine\u2013glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife. 2008;3:e02523. https:\/\/doi.org\/10.7554\/eLife.02523. Cited 24 Nov 2025.","DOI":"10.7554\/eLife.02523"},{"key":"2666_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","volume":"3","author":"S Dolma","year":"2003","unstructured":"Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3:285\u201396. https:\/\/doi.org\/10.1016\/S1535-6108(03)00050-3. [cited 2025 Nov 24].","journal-title":"Cancer Cell"},{"key":"2666_CR20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nature05859","volume":"447","author":"N Yagoda","year":"2007","unstructured":"Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, et al. RAS\u2013RAF\u2013MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nat. 2007;447:865\u20139. https:\/\/doi.org\/10.1038\/nature05859. [cited 2025 Nov 24].","journal-title":"Nat"},{"key":"2666_CR21","doi-asserted-by":"publisher","unstructured":"Yang WS, Stockwell BR. Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells. Chemistry & Biology. 2008;15:234\u201345. https:\/\/doi.org\/10.1016\/j.chembiol.2008.02.010. Cited 24 Nov 2025.","DOI":"10.1016\/j.chembiol.2008.02.010"},{"key":"2666_CR22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20:1181\u201392. https:\/\/doi.org\/10.1038\/s41556-018-0178-0. [cited 2025 Nov 24].","journal-title":"Nat Cell Biol"},{"key":"2666_CR23","doi-asserted-by":"publisher","first-page":"eabj9141","DOI":"10.1126\/sciadv.abj9141","volume":"7","author":"S Egolf","year":"2021","unstructured":"Egolf S, Zou J, Anderson A, Simpson CL, Aubert Y, Prouty S, et al. MLL4 mediates differentiation and tumor suppression through ferroptosis. Sci Adv. 2021;7:eabj9141. https:\/\/doi.org\/10.1126\/sciadv.abj9141. [cited 2025 Nov 24].","journal-title":"Sci Adv"},{"key":"2666_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang S-J, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nat. 2015;520:57\u201362. https:\/\/doi.org\/10.1038\/nature14344. [cited 2025 Nov 24].","journal-title":"Nat"},{"key":"2666_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nat. 2017;551:247\u201350. https:\/\/doi.org\/10.1038\/nature24297. [cited 2025 Nov 24].","journal-title":"Nat"},{"key":"2666_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nat. 2017;547:453\u20137. https:\/\/doi.org\/10.1038\/nature23007. [cited 2025 Nov 24].","journal-title":"Nat"},{"key":"2666_CR27","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","volume":"33","author":"J Tsoi","year":"2018","unstructured":"Tsoi J, Robert L, Paraiso K, Galvan C, Sheu KM, Lay J, et al. Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress. Cancer Cell. 2018;33:890\u2013e9045. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.017. [cited 2025 Nov 24].","journal-title":"Cancer Cell"},{"key":"2666_CR28","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3389\/fphar.2017.00992","volume":"8","author":"B Lu","year":"2017","unstructured":"Lu B, Chen XB, Ying MD, He QJ, Cao J, Yang B. The Role of Ferroptosis in Cancer Development and Treatment Response. Front Pharmacol. 2017;8:992. https:\/\/doi.org\/10.3389\/fphar.2017.00992. [cited 2025 Nov 24].","journal-title":"Front Pharmacol"},{"key":"2666_CR29","doi-asserted-by":"publisher","unstructured":"Pandrangi SL, Chittineedi P, Chalumuri SS, Meena AS, Neira Mosquera JA, S\u00e1nchez Llaguno SN et al. Role of intracellular iron in switching apoptosis to ferroptosis to target therapy-resistant cancer stem cells. Molecules. 2021;27:3011. https:\/\/doi.org\/10.3390\/molecules27093011.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.3390\/molecules27093011"},{"key":"2666_CR30","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-20-3477","volume":"81","author":"A Ghoochani","year":"2021","unstructured":"Ghoochani A, Hsu E-C, Aslan M, Rice MA, Nguyen HM, Brooks JD, et al. Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer. Cancer Res. 2021;81:1583\u201394. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-3477. [cited 2025 Nov 24].","journal-title":"Cancer Res"},{"key":"2666_CR31","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","volume":"117","author":"J Yi","year":"2020","unstructured":"Yi J, Zhu J, Wu J, Thompson CB, Jiang X. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci USA. 2020;117:31189\u201397. https:\/\/doi.org\/10.1073\/pnas.2017152117. [cited 2025 Nov 24].","journal-title":"Proc Natl Acad Sci USA"},{"key":"2666_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396. https:\/\/doi.org\/10.1038\/s41568-022-00459-0. [cited 2025 Nov 24].","journal-title":"Nat Rev Cancer"},{"key":"2666_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2017.99","volume":"18","author":"E Anastasiadou","year":"2018","unstructured":"Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18:5\u201318. https:\/\/doi.org\/10.1038\/nrc.2017.99. [cited 2025 Nov 24].","journal-title":"Nat Rev Cancer"},{"key":"2666_CR34","doi-asserted-by":"publisher","unstructured":"Li B, Yang L, Peng X, Fan Q, Wei S, Yang S et al. Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers. Biomed Pharmacotherapy. 2020;130:110710. https:\/\/doi.org\/10.1016\/j.biopha.2020.110710.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.biopha.2020.110710"},{"key":"2666_CR35","doi-asserted-by":"publisher","unstructured":"Xu H, Ye D, Ren M, Zhang H, Bi F. Ferroptosis in the tumor microenvironment: perspectives for immunotherapy. Trends in Molecular Medicine. 2021;27:856\u201367. https:\/\/doi.org\/10.1016\/j.molmed.2021.06.014.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.molmed.2021.06.014"},{"key":"2666_CR36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016. [cited 2025 Nov 24].","journal-title":"Cancer Cell"},{"key":"2666_CR37","doi-asserted-by":"publisher","unstructured":"Kim R, Taylor D, Vonderheide RH, Gabrilovich DI. Ferroptosis of immune cells in the tumor microenvironment. Trends in Pharmacological Sciences. 2023;44:542\u201352. https:\/\/doi.org\/10.1016\/j.tips.2023.06.005. Cited 24 Nov 2025.","DOI":"10.1016\/j.tips.2023.06.005"},{"key":"2666_CR38","doi-asserted-by":"publisher","unstructured":"Efimova I, Catanzaro E, Van der Meeren L, Turubanova VD, Hammad H, Mishchenko TA et al. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J Immunother Cancer. 2020;8:e001369. https:\/\/doi.org\/10.1136\/jitc-2020-001369.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1136\/jitc-2020-001369"},{"key":"2666_CR39","doi-asserted-by":"publisher","unstructured":"Conrad M, Sato H. The oxidative stress-inducible cystine\/glutamate antiporter, system x c \u2013: cystine supplier and beyond. Amino Acids. 2012;42:231\u201346. https:\/\/doi.org\/10.1007\/s00726-011-0867-5.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1007\/s00726-011-0867-5"},{"key":"2666_CR40","doi-asserted-by":"publisher","unstructured":"Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW et al. The cystine\/glutamate antiporter system xc\u2013in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013;18:522\u201355. https:\/\/doi.org\/10.1089\/ars.2011.4391.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1089\/ars.2011.4391"},{"key":"2666_CR41","first-page":"3106","volume":"10","author":"W Lin","year":"2020","unstructured":"Lin W, Wang C, Liu G, Bi C, Wang X, Zhou Q, et al. SLC7A11\/xCT in cancer: biological functions and therapeutic implications. Am J Cancer Res. 2020;10:3106\u201326.","journal-title":"Am J Cancer Res"},{"key":"2666_CR42","doi-asserted-by":"publisher","first-page":"910292","DOI":"10.3389\/fphar.2022.910292","volume":"13","author":"F-J Li","year":"2022","unstructured":"Li F-J, Long H-Z, Zhou Z-W, Luo H-Y, Xu S-G, Gao L-C. System Xc\u2013\/GSH\/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol. 2022;13:910292. https:\/\/doi.org\/10.3389\/fphar.2022.910292.","journal-title":"Front Pharmacol"},{"key":"2666_CR43","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, et al. Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11. Cancer Discov. 2019;9:1673\u201385. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0338. [cited 2025 Nov 24].","journal-title":"Cancer Discov"},{"key":"2666_CR44","doi-asserted-by":"publisher","unstructured":"Deponte M. Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes. Biochimica et Biophysica Acta (BBA) - General Subjects. 2013;1830:3217\u201366. https:\/\/doi.org\/10.1016\/j.bbagen.2012.09.018.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.bbagen.2012.09.018"},{"key":"2666_CR45","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1038\/oncsis.2017.65","volume":"6","author":"Z Fan","year":"2019","unstructured":"Fan Z, Wirth A-K, Chen D, Wruck CJ, Rauh M, Buchfelder M, et al. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncog. 2019;6:e371\u2013371. https:\/\/doi.org\/10.1038\/oncsis.2017.65. [cited 2025 Nov 24].","journal-title":"Oncog"},{"key":"2666_CR46","doi-asserted-by":"publisher","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biology. 2019;23:101107. https:\/\/doi.org\/10.1016\/j.redox.2019.101107.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.redox.2019.101107"},{"key":"2666_CR47","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1042\/BST20220682","volume":"50","author":"T Nishida Xavier da Silva","year":"2022","unstructured":"Nishida Xavier da Silva T, Friedmann Angeli JP, Ingold I. GPX4: old lessons, new features. Biochem Soc Trans. 2022;50:1205\u201313. https:\/\/doi.org\/10.1042\/BST20220682. [cited 2025 Nov 24].","journal-title":"Biochem Soc Trans"},{"key":"2666_CR48","doi-asserted-by":"publisher","unstructured":"Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic Biol Med 2020;152:175\u201385. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.02.027.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.freeradbiomed.2020.02.027"},{"key":"2666_CR49","doi-asserted-by":"publisher","unstructured":"Seibt TM, Proneth B, Conrad M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med. 2019;133:144\u201352. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.09.014.\u00a0 Cited 24 Nov 2025.","DOI":"10.1016\/j.freeradbiomed.2018.09.014"},{"key":"2666_CR50","doi-asserted-by":"publisher","unstructured":"Liu Y, Wan Y, Jiang Y, Zhang L, Cheng W. GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023;1878:188890. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188890.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.bbcan.2023.188890"},{"key":"2666_CR51","doi-asserted-by":"publisher","unstructured":"Shin D, Kim EH, Lee J, Roh J-L. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer. Free Radic Biol Med. 2018;129:454\u201362. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.10.426.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.freeradbiomed.2018.10.426"},{"key":"2666_CR52","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41419-021-03718-4","volume":"12","author":"Q Wang","year":"2019","unstructured":"Wang Q, Bin C, Xue Q, Gao Q, Huang A, Wang K, et al. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2\/GPX4 axis. Cell Death Dis. 2019;12:426. https:\/\/doi.org\/10.1038\/s41419-021-03718-4. [cited 2025 Nov 24].","journal-title":"Cell Death Dis"},{"key":"2666_CR53","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nat. 2019;575:693\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1707-0. [cited 2025 Nov 24].","journal-title":"Nat"},{"key":"2666_CR54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s43556-022-00105-z","volume":"3","author":"F Zeng","year":"2022","unstructured":"Zeng F, Chen X, Deng G. The anti-ferroptotic role of FSP1: current molecular mechanism and therapeutic approach. Mol Biomed. 2022;3:37. https:\/\/doi.org\/10.1186\/s43556-022-00105-z. [cited 2025 Nov 24].","journal-title":"Mol Biomed"},{"key":"2666_CR55","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","volume":"608","author":"E Mishima","year":"2022","unstructured":"Mishima E, Ito J, Wu Z, Nakamura T, Wahida A, Doll S, et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nat. 2022;608:778\u201383. https:\/\/doi.org\/10.1038\/s41586-022-05022-3. [cited 2025 Nov 24].","journal-title":"Nat"},{"key":"2666_CR56","doi-asserted-by":"publisher","unstructured":"Dai E, Zhang W, Cong D, Kang R, Wang J, Tang D. AIFM2 blocks ferroptosis independent of ubiquinol metabolism. Biochem Biophys Res Commun. 2020;523:966\u201371. https:\/\/doi.org\/10.1016\/j.bbrc.2020.01.066.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.bbrc.2020.01.066"},{"key":"2666_CR57","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2023","unstructured":"Koppula P, Lei G, Zhang Y, Yan Y, Mao C, Kondiparthi L, et al. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun. 2023;13:2206. https:\/\/doi.org\/10.1038\/s41467-022-29905-1. [cited 2025 Nov 24].","journal-title":"Nat Commun"},{"key":"2666_CR58","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41418-022-01096-8","volume":"30","author":"F M\u00fcller","year":"2023","unstructured":"M\u00fcller F, Lim JKM, Bebber CM, Seidel E, Tishina S, Dahlhaus A, et al. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation. Cell Death Differ. 2023;30:442\u201356. https:\/\/doi.org\/10.1038\/s41418-022-01096-8. [cited 2025 Nov 24].","journal-title":"Cell Death Differ"},{"key":"2666_CR59","doi-asserted-by":"publisher","unstructured":"Li W, Liang L, Liu S, Yi H, Zhou Y. FSP1: a key regulator of ferroptosis. Trends Mol Med. 2023;29:753\u201364. https:\/\/doi.org\/10.1016\/j.molmed.2023.05.013.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.molmed.2023.05.013"},{"key":"2666_CR60","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41586-023-06255-6","volume":"619","author":"T Nakamura","year":"2023","unstructured":"Nakamura T, Hipp C, Santos Dias Mour\u00e3o A, Borggr\u00e4fe J, Aldrovandi M, Henkelmann B, et al. Phase separation of FSP1 promotes ferroptosis. Nat. 2023;619:371\u20137. https:\/\/doi.org\/10.1038\/s41586-023-06255-6. [cited 2025 Nov 24].","journal-title":"Nat"},{"key":"2666_CR61","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41568-023-00607-0","volume":"23","author":"G Brewer","year":"2023","unstructured":"Brewer G. FSP1 in cancer: not just a phase. Nat Rev Cancer. 2023;23:578\u2013578. https:\/\/doi.org\/10.1038\/s41568-023-00607-0. [cited 2025 Nov 24].","journal-title":"Nat Rev Cancer"},{"key":"2666_CR62","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41392-021-00656-7","volume":"6","author":"F Wang","year":"2021","unstructured":"Wang F, Min J. DHODH tangoing with GPX4 on the ferroptotic stage. Signal Transduct Target Ther. 2021;6:244. https:\/\/doi.org\/10.1038\/s41392-021-00656-7.","journal-title":"Signal Transduct Target Ther"},{"key":"2666_CR63","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593:586\u201390. https:\/\/doi.org\/10.1038\/s41586-021-03539-7.","journal-title":"Nature"},{"key":"2666_CR64","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12964-022-01025-9","volume":"21","author":"A Amos","year":"2023","unstructured":"Amos A, Amos A, Wu L, Xia H. The Warburg effect modulates DHODH role in ferroptosis: a review. Cell Commun Signal. 2023;21:100. https:\/\/doi.org\/10.1186\/s12964-022-01025-9.","journal-title":"Cell Commun Signal"},{"key":"2666_CR65","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1038\/s41467-025-59307-y","volume":"16","author":"D Teng","year":"2025","unstructured":"Teng D, Swanson KD, Wang R, Zhuang A, Wu H, Niu Z, et al. DHODH modulates immune evasion of cancer cells via CDP-Choline dependent regulation of phospholipid metabolism and ferroptosis. Nat Commun. 2025;16:3867. https:\/\/doi.org\/10.1038\/s41467-025-59307-y.","journal-title":"Nat Commun"},{"key":"2666_CR66","doi-asserted-by":"publisher","first-page":"103788","DOI":"10.1016\/j.redox.2025.103788","volume":"85","author":"J Cao","year":"2025","unstructured":"Cao J, Chen X, Chen L, Lu Y, Wu Y, Deng A, et al. DHODH-mediated mitochondrial redox homeostasis: a novel ferroptosis regulator and promising therapeutic target. Redox Biol. 2025;85:103788. https:\/\/doi.org\/10.1016\/j.redox.2025.103788.","journal-title":"Redox Biol"},{"key":"2666_CR67","doi-asserted-by":"publisher","unstructured":"Anderson GJ, Frazer DM. Current understanding of iron homeostasis. Am J Clin Nutr. 2017;106. https:\/\/doi.org\/10.3945\/ajcn.117.155804. :1559S-1566S.","DOI":"10.3945\/ajcn.117.155804"},{"key":"2666_CR68","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1152\/physrev.00008.2013","volume":"93","author":"T Ganz","year":"2013","unstructured":"Ganz T. Systemic iron homeostasis. Physiol Rev. 2013;93:1721\u201341. https:\/\/doi.org\/10.1152\/physrev.00008.2013.","journal-title":"Physiol Rev"},{"key":"2666_CR69","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.3390\/ijms22126493","volume":"22","author":"E Nemeth","year":"2021","unstructured":"Nemeth E, Ganz T. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis. Int J Mol Sci. 2021;22:6493. https:\/\/doi.org\/10.3390\/ijms22126493.","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"2666_CR70","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ijlh.12505","volume":"38","author":"C Camaschella","year":"2016","unstructured":"Camaschella C, Pagani A, Nai A, Silvestri L. The mutual control of iron and erythropoiesis. Int J Lab Hematol. 2016;38(Suppl 1):20\u20136. https:\/\/doi.org\/10.1111\/ijlh.12505.","journal-title":"Int J Lab Hematol"},{"key":"2666_CR71","doi-asserted-by":"publisher","first-page":"BSR20170195","DOI":"10.1042\/BSR20170195","volume":"37","author":"G Rishi","year":"2017","unstructured":"Rishi G, Subramaniam VN. The relationship between systemic iron homeostasis and erythropoiesis. Biosci Rep. 2017;37:BSR20170195. https:\/\/doi.org\/10.1042\/BSR20170195.","journal-title":"Biosci Rep"},{"key":"2666_CR72","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1182\/blood.2020005351","volume":"136","author":"TRL Klei","year":"2020","unstructured":"Klei TRL, Dalimot J, Nota B, Veldthuis M, Mul FPJ, Rademakers T, et al. Hemolysis in the spleen drives erythrocyte turnover. Blood. 2020;136:1579\u201389. https:\/\/doi.org\/10.1182\/blood.2020005351.","journal-title":"Blood"},{"key":"2666_CR73","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fimmu.2017.00073","volume":"8","author":"TRL Klei","year":"2017","unstructured":"Klei TRL, Meinderts SM, van den Berg TK, van Bruggen R. From the Cradle to the Grave: The Role of Macrophages in Erythropoiesis and Erythrophagocytosis. Front Immunol. 2017;8:73. https:\/\/doi.org\/10.3389\/fimmu.2017.00073.","journal-title":"Front Immunol"},{"key":"2666_CR74","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41581-019-0197-5","volume":"16","author":"RPL van Swelm","year":"2020","unstructured":"van Swelm RPL, Wetzels JFM, Swinkels DW. The multifaceted role of iron in renal health and disease. Nat Rev Nephrol. 2020;16:77\u201398. https:\/\/doi.org\/10.1038\/s41581-019-0197-5.","journal-title":"Nat Rev Nephrol"},{"key":"2666_CR75","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41581-023-00689-x","volume":"19","author":"H Bay\u0131r","year":"2023","unstructured":"Bay\u0131r H, Dixon SJ, Tyurina YY, Kellum JA, Kagan VE. Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney. Nat Rev Nephrol. 2023;19:315\u201336. https:\/\/doi.org\/10.1038\/s41581-023-00689-x.","journal-title":"Nat Rev Nephrol"},{"key":"2666_CR76","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3390\/cancers14071826","volume":"14","author":"D Bekric","year":"2022","unstructured":"Bekric D, Ocker M, Mayr C, Stintzing S, Ritter M, Kiesslich T, et al. Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation. Cancers (Basel). 2022;14:1826. https:\/\/doi.org\/10.3390\/cancers14071826.","journal-title":"Cancers (Basel)"},{"key":"2666_CR77","doi-asserted-by":"publisher","first-page":"590226","DOI":"10.3389\/fcell.2020.590226","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen X, Yu C, Kang R, Tang D. Iron Metabolism in Ferroptosis. Front Cell Dev Biol. 2020;8:590226. https:\/\/doi.org\/10.3389\/fcell.2020.590226. [cited 2025 Nov 24].","journal-title":"Front Cell Dev Biol"},{"key":"2666_CR78","doi-asserted-by":"publisher","unstructured":"Ganz T. Systemic iron homeostasis. Physiol Rev. 2013;93:1721\u201341. https:\/\/doi.org\/10.1152\/physrev.00008.2013. Cited 24 Nov 2025.","DOI":"10.1152\/physrev.00008.2013"},{"key":"2666_CR79","doi-asserted-by":"publisher","unstructured":"Nemeth E, Ganz T. Hepcidin-ferroportin interaction controls systemic iron homeostasis. IJMS. 2013;22:6493. https:\/\/doi.org\/10.3390\/ijms22126493. Cited 24 Nov 2025.","DOI":"10.3390\/ijms22126493"},{"key":"2666_CR80","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang X, Ardehali H, Min J, Wang F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol. 2023;20:7\u201323. https:\/\/doi.org\/10.1038\/s41569-022-00735-4. [cited 2025 Nov 24].","journal-title":"Nat Rev Cardiol"},{"key":"2666_CR81","doi-asserted-by":"publisher","unstructured":"Transferrin-mediated cellular iron delivery. Current Topics in Membranes. Elsevier. 2012:3\u201335. https:\/\/doi.org\/10.1016\/B978-0-12-394390-3.00001-X.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/B978-0-12-394390-3.00001-X"},{"key":"2666_CR82","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.tem.2013.07.003","volume":"24","author":"M Bayeva","year":"2013","unstructured":"Bayeva M, Chang H-C, Wu R, Ardehali H. When less is more: novel mechanisms of iron conservation. Trends Endocrinol Metabolism. 2013;24:569\u201377. https:\/\/doi.org\/10.1016\/j.tem.2013.07.003. [cited 2025 Nov 24].","journal-title":"Trends Endocrinol Metabolism"},{"key":"2666_CR83","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nchembio807","volume":"2","author":"TA Rouault","year":"2006","unstructured":"Rouault TA. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol. 2006;2:406\u201314. https:\/\/doi.org\/10.1038\/nchembio807. [cited 2025 Nov 24].","journal-title":"Nat Chem Biol"},{"key":"2666_CR84","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature13148","volume":"509","author":"JD Mancias","year":"2014","unstructured":"Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nat. 2014;509:105\u20139. https:\/\/doi.org\/10.1038\/nature13148. [cited 2025 Nov 24].","journal-title":"Nat"},{"key":"2666_CR85","doi-asserted-by":"publisher","unstructured":"Mancias JD, Pontano Vaites L, Nissim S, Biancur DE, Kim AJ, Wang X et al. Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis. eLife. 2023;4:e10308. https:\/\/doi.org\/10.7554\/eLife.10308.\u00a0 Cited 24 Nov 2025.","DOI":"10.7554\/eLife.10308"},{"key":"2666_CR86","doi-asserted-by":"publisher","unstructured":"Quiles del Rey M, Mancias JD. NCOA4-mediated ferritinophagy: a potential link to neurodegeneration. Front Neurosci. 2023;13:238. https:\/\/doi.org\/10.3389\/fnins.2019.00238.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.3389\/fnins.2019.00238"},{"key":"2666_CR87","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12:1425\u20138. https:\/\/doi.org\/10.1080\/15548627.2016.1187366. [cited 2025 Nov 24].","journal-title":"Autophagy"},{"key":"2666_CR88","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1023\/B:MCBI.0000009862.17396.8d","volume":"256\u2013257","author":"MVDAC Colombini","year":"2004","unstructured":"Colombini MVDAC. The channel at the interface between mitochondria and the cytosol. Mol Cell Biochem. 2004;256\u2013257:107\u201315. https:\/\/doi.org\/10.1023\/B:MCBI.0000009862.17396.8d. [cited 2025 Nov 24].","journal-title":"Mol Cell Biochem"},{"key":"2666_CR89","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/cells9061505","volume":"9","author":"AM Battaglia","year":"2022","unstructured":"Battaglia AM, Chirillo R, Aversa I, Sacco A, Costanzo F, Biamonte F. Ferroptosis and Cancer: Mitochondria Meet the Iron Maiden. Cell Death Cells. 2022;9:1505. https:\/\/doi.org\/10.3390\/cells9061505. [cited 2025 Nov 24].","journal-title":"Cell Death Cells"},{"key":"2666_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00308","author":"Y-Q Wang","year":"2016","unstructured":"Wang Y-Q, Chang S-Y, Wu Q, Gou Y-J, Jia L, Cui Y-M, et al. The Protective Role of Mitochondrial Ferritin on Erastin-Induced Ferroptosis. Front Aging Neurosci. 2016. https:\/\/doi.org\/10.3389\/fnagi.2016.00308. [cited 2025 Nov 24]8.","journal-title":"Front Aging Neurosci"},{"key":"2666_CR91","doi-asserted-by":"publisher","unstructured":"Gao G, Zhang N, Wang Y-Q, Wu Q, Yu P, Shi Z-H et al. Mitochondrial ferritin protects hydrogen peroxide-induced neuronal cell damage. Aging and disease. 2017;8:458. https:\/\/doi.org\/10.14336\/AD.2016.1108.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.14336\/AD.2016.1108"},{"key":"2666_CR92","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185:2401\u201321. https:\/\/doi.org\/10.1016\/j.cell.2022.06.003. [cited 2025 Nov 24].","journal-title":"Cell"},{"key":"2666_CR93","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan VE, Mao G, Qu F, Angeli JPF, Doll S, Croix CS, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81\u201390. https:\/\/doi.org\/10.1038\/nchembio.2238. [cited 2025 Nov 24].","journal-title":"Nat Chem Biol"},{"key":"2666_CR94","doi-asserted-by":"publisher","unstructured":"Li D, Li Y. The interaction between ferroptosis and lipid metabolism in cancer. Sig Transduct Target Ther. 2020;5:108. https:\/\/doi.org\/10.1038\/s41392-020-00216-5.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1038\/s41392-020-00216-5"},{"key":"2666_CR95","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1021\/cr200084z","volume":"111","author":"H Yin","year":"2011","unstructured":"Yin H, Xu L, Porter NA. Free Radical Lipid Peroxidation: Mechanisms and Analysis. Chem Rev. 2011;111:5944\u201372. https:\/\/doi.org\/10.1021\/cr200084z. [cited 2025 Nov 24].","journal-title":"Chem Rev"},{"key":"2666_CR96","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.chembiol.2022.06.004","volume":"29","author":"L Magtanong","year":"2022","unstructured":"Magtanong L, Mueller GD, Williams KJ, Billmann M, Chan K, Armenta DA, et al. Context-dependent regulation of ferroptosis sensitivity. Cell Chem Biology. 2022;29:1409\u2013e14186. https:\/\/doi.org\/10.1016\/j.chembiol.2022.06.004. [cited 2025 Nov 24].","journal-title":"Cell Chem Biology"},{"key":"2666_CR97","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","volume":"21","author":"B Chu","year":"2019","unstructured":"Chu B, Kon N, Chen D, Li T, Liu T, Jiang L, et al. ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. Nat Cell Biol. 2019;21:579\u201391. https:\/\/doi.org\/10.1038\/s41556-019-0305-6. [cited 2025 Nov 24].","journal-title":"Nat Cell Biol"},{"key":"2666_CR98","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-022-01297-1","volume":"15","author":"Y Xie","year":"2022","unstructured":"Xie Y, Wang B, Zhao Y, Tao Z, Wang Y, Chen G, et al. Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis. J Hematol Oncol. 2022;15:72. https:\/\/doi.org\/10.1186\/s13045-022-01297-1. [cited 2025 Nov 24].","journal-title":"J Hematol Oncol"},{"key":"2666_CR99","doi-asserted-by":"publisher","unstructured":"Yang Y, Zhu T, Wang X, Xiong F, Hu Z, Qiao X et al. ACSL3 and ACSL4, distinct roles in ferroptosis and cancers. Cancers. 2016;14:5896. https:\/\/doi.org\/10.3390\/cancers14235896.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.3390\/cancers14235896"},{"key":"2666_CR100","doi-asserted-by":"publisher","unstructured":"Zhou Q, Tao C, Yuan J, Pan F, Wang R. Ferroptosis, a subtle talk between immune system and cancer cells: To be or not to be? Biomed Pharmacother. 2023;165:115251. https:\/\/doi.org\/10.1016\/j.biopha.2023.115251.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.biopha.2023.115251"},{"key":"2666_CR101","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41586-019-0904-1","volume":"566","author":"K Vriens","year":"2019","unstructured":"Vriens K, Christen S, Parik S, Broekaert D, Yoshinaga K, Talebi A, et al. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity. Nat. 2019;566:403\u20136. https:\/\/doi.org\/10.1038\/s41586-019-0904-1. [cited 2025 Nov 24].","journal-title":"Nat"},{"key":"2666_CR102","doi-asserted-by":"publisher","unstructured":"Xu R, Wang W, Zhang W. Ferroptosis and the bidirectional regulatory factor p53. Cell Death Discov. 2017;9:197. https:\/\/doi.org\/10.1038\/s41420-023-01517-8. Cited 24 Nov 2025.","DOI":"10.1038\/s41420-023-01517-8"},{"key":"2666_CR103","doi-asserted-by":"publisher","unstructured":"Liu Y, Gu W. p53 in ferroptosis regulation: the new weapon for the old guardian. Cell Death Differ. 2022;29:895\u2013910. https:\/\/doi.org\/10.1038\/s41418-022-00943-y.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1038\/s41418-022-00943-y"},{"key":"2666_CR104","doi-asserted-by":"publisher","unstructured":"Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci USA. 2010;107:7455\u201360. https:\/\/doi.org\/10.1073\/pnas.1001006107.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1073\/pnas.1001006107"},{"key":"2666_CR105","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1101\/gad.299388.117","volume":"31","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Qian Y, Zhang J, Yan W, Jung Y-S, Chen M, et al. Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2. Genes Dev. 2017;31:1243\u201356. https:\/\/doi.org\/10.1101\/gad.299388.117. [cited 2025 Nov 24].","journal-title":"Genes Dev"},{"key":"2666_CR106","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.redox.2020.101619","volume":"36","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Guo M, Shen M, Kong D, Zhang F, Shao J, et al. The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells. Redox Biology. 2020;36:101619. https:\/\/doi.org\/10.1016\/j.redox.2020.101619. [cited 2025 Nov 24].","journal-title":"Redox Biology"},{"key":"2666_CR107","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1607152113","author":"Y Ou","year":"2016","unstructured":"Ou Y, Wang S-J, Li D, Chu B, Gu W. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci USA. 2016. https:\/\/doi.org\/10.1073\/pnas.1607152113. [cited 2025 Nov 24];113.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2666_CR108","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41389-021-00304-3","volume":"10","author":"X Yang","year":"2021","unstructured":"Yang X, Liu J, Wang C, Cheng KK, Xu H, Li Q, et al. miR-18a promotes glioblastoma development by down-regulating ALOXE3-mediated ferroptotic and anti-migration activities. Oncog. 2021;10:15. https:\/\/doi.org\/10.1038\/s41389-021-00304-3. [cited 2025 Nov 24].","journal-title":"Oncog"},{"key":"2666_CR109","doi-asserted-by":"publisher","unstructured":"Kerins MJ, Ooi A. The roles of NRF2 in modulating cellular iron homeostasis. Antioxid Redox Signal. 2018;29:1756\u201373. https:\/\/doi.org\/10.1089\/ars.2017.7176.\u00a0 Cited 24 Nov 2025.","DOI":"10.1089\/ars.2017.7176"},{"key":"2666_CR110","doi-asserted-by":"publisher","unstructured":"Bellezza I, Giambanco I, Minelli A, Donato R. Nrf2-Keap1 signaling in oxidative and reductive stress. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2018;1865:721\u201333. https:\/\/doi.org\/10.1016\/j.bbamcr.2018.02.010.\u00a0 Cited 24 Nov 2025.","DOI":"10.1016\/j.bbamcr.2018.02.010"},{"key":"2666_CR111","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrc3166","volume":"11","author":"AL Kasinski","year":"2011","unstructured":"Kasinski AL, Slack FJ. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer. 2011;11:849\u201364. https:\/\/doi.org\/10.1038\/nrc3166. [cited 2025 Nov 24].","journal-title":"Nat Rev Cancer"},{"key":"2666_CR112","doi-asserted-by":"publisher","first-page":"100851","DOI":"10.1016\/j.drup.2022.100851","volume":"63","author":"D Singh","year":"2022","unstructured":"Singh D, Assaraf YG, Gacche RN. Long non-coding RNA mediated drug resistance in breast cancer. Drug Resist Updates. 2022;63:100851. https:\/\/doi.org\/10.1016\/j.drup.2022.100851. [cited 2025 Nov 24].","journal-title":"Drug Resist Updates"},{"key":"2666_CR113","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12943-023-01801-2","volume":"22","author":"Y Wu","year":"2023","unstructured":"Wu Y, Song Y, Wang R, Wang T. Molecular mechanisms of tumor resistance to radiotherapy. Mol Cancer. 2023;22:96. https:\/\/doi.org\/10.1186\/s12943-023-01801-2. [cited 2025 Nov 24].","journal-title":"Mol Cancer"},{"key":"2666_CR114","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13045-023-01452-2","volume":"16","author":"F Zhang","year":"2023","unstructured":"Zhang F, Jiang J, Qian H, Yan Y, Xu W. Exosomal circRNA: emerging insights into cancer progression and clinical application potential. J Hematol Oncol. 2023;16:67. https:\/\/doi.org\/10.1186\/s13045-023-01452-2. [cited 2025 Nov 24].","journal-title":"J Hematol Oncol"},{"key":"2666_CR115","doi-asserted-by":"publisher","unstructured":"Yuan Y, Mei Z, Qu Z, Li G, Yu S, Liu Y et al. Exosomes secreted from cardiomyocytes suppress the sensitivity of tumor ferroptosis in ischemic heart failure. Sig Transduct Target Ther. 2017;8:121. https:\/\/doi.org\/10.1038\/s41392-023-01336-4.\u00a0 Cited 24 Nov 2025.","DOI":"10.1038\/s41392-023-01336-4"},{"key":"2666_CR116","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-017-0663-2","volume":"16","author":"S Meng","year":"2017","unstructured":"Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16:94. https:\/\/doi.org\/10.1186\/s12943-017-0663-2. [cited 2025 Nov 24].","journal-title":"Mol Cancer"},{"key":"2666_CR117","doi-asserted-by":"publisher","unstructured":"Rong Z, Xu J, Shi S, Tan Z, Meng Q, Hua J et al. Circular RNA in pancreatic cancer: a novel avenue for the roles of diagnosis and treatment. Theranostics. 2021;11:2755\u201369. https:\/\/doi.org\/10.7150\/thno.56174.\u00a0Cited 24 Nov 2025.","DOI":"10.7150\/thno.56174"},{"key":"2666_CR118","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ccr.2014.07.009","volume":"26","author":"X Hu","year":"2014","unstructured":"Hu X, Feng Y, Zhang D, Zhao SD, Hu Z, Greshock J, et al. A Functional Genomic Approach Identifies FAL1 as an Oncogenic Long Noncoding RNA that Associates with BMI1 and Represses p21 Expression in Cancer. Cancer Cell. 2014;26:344\u201357. https:\/\/doi.org\/10.1016\/j.ccr.2014.07.009. [cited 2025 Nov 24].","journal-title":"Cancer Cell"},{"key":"2666_CR119","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature22992","volume":"547","author":"E Rheinbay","year":"2017","unstructured":"Rheinbay E, Parasuraman P, Grimsby J, Tiao G, Engreitz JM, Kim J, et al. Recurrent and functional regulatory mutations in breast cancer. Nat. 2017;547:55\u201360. https:\/\/doi.org\/10.1038\/nature22992. [cited 2025 Nov 24].","journal-title":"Nat"},{"key":"2666_CR120","doi-asserted-by":"publisher","first-page":"1903233","DOI":"10.1002\/advs.201903233","volume":"7","author":"N Meng","year":"2020","unstructured":"Meng N, Chen M, Chen D, Chen X, Wang J, Zhu S, et al. Small Protein Hidden in lncRNA LOC90024 Promotes Cancerous RNA Splicing and Tumorigenesis. Adv Sci. 2020;7:1903233. https:\/\/doi.org\/10.1002\/advs.201903233. [cited 2025 Nov 24].","journal-title":"Adv Sci"},{"key":"2666_CR121","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2020.10.002","volume":"497","author":"B Zhou","year":"2021","unstructured":"Zhou B, Yang H, Yang C, Bao Y, Yang S, Liu J, et al. Translation of noncoding RNAs and cancer. Cancer Lett. 2021;497:89\u201399. https:\/\/doi.org\/10.1016\/j.canlet.2020.10.002. [cited 2025 Nov 24].","journal-title":"Cancer Lett"},{"key":"2666_CR122","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. Cancer Cell. 2020;37:270\u201388. https:\/\/doi.org\/10.1016\/j.ccell.2020.02.004. [cited 2025 Nov 24].","journal-title":"Cancer Cell"},{"key":"2666_CR123","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-025-02544-y","volume":"25","author":"F Guo","year":"2026","unstructured":"Guo F, Zong S, Zhang X, Ren Z, Shao H, Li J, et al. Ferroptosis and metastasis: molecular checkpoints, microenvironmental dynamics, and therapeutic opportunities. Mol Cancer. 2026;25:45. https:\/\/doi.org\/10.1186\/s12943-025-02544-y.","journal-title":"Mol Cancer"},{"key":"2666_CR124","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13046-023-02925-5","volume":"43","author":"Y Hua","year":"2024","unstructured":"Hua Y, Yang S, Zhang Y, Li J, Wang M, Yeerkenbieke P, et al. Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment. J Exp Clin Cancer Res. 2024;43:19. https:\/\/doi.org\/10.1186\/s13046-023-02925-5.","journal-title":"J Exp Clin Cancer Res"},{"key":"2666_CR125","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1016\/j.apsb.2025.09.043","volume":"15","author":"L Gan","year":"2025","unstructured":"Gan L, Lin X, Zhong Z, Zheng Y, Chen X, Chen J, et al. Ferroptosis meets cancer immunotherapy: Overcoming the crosstalk challenges through advanced drug delivery strategies. Acta Pharm Sin B. 2025;15:6307\u201341. https:\/\/doi.org\/10.1016\/j.apsb.2025.09.043.","journal-title":"Acta Pharm Sin B"},{"key":"2666_CR126","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bioactmat.2021.11.013","volume":"13","author":"R Zhang","year":"2022","unstructured":"Zhang R, Pan T, Xiang Y, Zhang M, Xie H, Liang Z, et al. Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19\/miR-19b-3p\/FTH1 axis. Bioact Mater. 2022;13:23\u201336. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.11.013.","journal-title":"Bioact Mater"},{"key":"2666_CR127","doi-asserted-by":"publisher","first-page":"106739","DOI":"10.1016\/j.phrs.2023.106739","volume":"191","author":"C Xu","year":"2023","unstructured":"Xu C, Jiang Z-B, Shao L, Zhao Z-M, Fan X-X, Sui X, et al. \u03b2-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer. Pharmacol Res. 2023;191:106739. https:\/\/doi.org\/10.1016\/j.phrs.2023.106739.","journal-title":"Pharmacol Res"},{"key":"2666_CR128","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/2211-5463.13314","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J, Qin C, Zhou Y, Chen Y, Mao M, Yang J. Metformin may induce ferroptosis by inhibiting autophagy via lncRNA H19 in breast cancer. FEBS Open Bio. 2022;12:146\u201353. https:\/\/doi.org\/10.1002\/2211-5463.13314.","journal-title":"FEBS Open Bio"},{"key":"2666_CR129","doi-asserted-by":"publisher","unstructured":"Zhang L, Meng X, Pan C, Qu F, Gan W, Xiang Z et al. piR-31470 epigenetically suppresses the expression of glutathione S-transferase pi 1 in prostate cancer via DNA methylation. Cell Signal. 2020;67:109501. https:\/\/doi.org\/10.1016\/j.cellsig.2019.109501.\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.cellsig.2019.109501"},{"key":"2666_CR130","doi-asserted-by":"publisher","first-page":"1102158","DOI":"10.3389\/fmolb.2022.1102158","volume":"9","author":"X Tan","year":"2022","unstructured":"Tan X, Huang X, Niu B, Guo X, Lei X, Qu B. Targeting GSTP1-dependent ferroptosis in lung cancer radiotherapy: Existing evidence and future directions. Front Mol Biosci. 2022;9:1102158. https:\/\/doi.org\/10.3389\/fmolb.2022.1102158. [cited 2025 Nov 24].","journal-title":"Front Mol Biosci"},{"key":"2666_CR131","doi-asserted-by":"publisher","first-page":"8115","DOI":"10.18632\/aging.202608","volume":"13","author":"H Zhang","year":"2021","unstructured":"Zhang H, Ge Z, Wang Z, Gao Y, Wang Y, Qu X. Circular RNA RHOT1 promotes progression and inhibits ferroptosis via mir-106a-5p\/STAT3 axis in breast cancer. Aging. 2021;13:8115\u201326. https:\/\/doi.org\/10.18632\/aging.202608. [cited 2025 Nov 24].","journal-title":"Aging"},{"key":"2666_CR132","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/tox.23509","volume":"37","author":"S Wang","year":"2022","unstructured":"Wang S, Wang Y, Li Q, Li X, Feng X. A novel circular RNA confers trastuzumab resistance in human epidermal growth factor receptor 2-positive breast cancer through regulating ferroptosis. Environ Toxicol. 2022;37:1597\u2013607. https:\/\/doi.org\/10.1002\/tox.23509. [cited 2025 Nov 24].","journal-title":"Environ Toxicol"},{"key":"2666_CR133","doi-asserted-by":"publisher","first-page":"10248","DOI":"10.1111\/jcmm.16963","volume":"25","author":"M Bazhabayi","year":"2021","unstructured":"Bazhabayi M, Qiu X, Li X, Yang A, Wen W, Zhang X, et al. CircGFRA1 facilitates the malignant progression of HER-2\u2010positive breast cancer via acting as a sponge of miR\u20101228 and enhancing AIFM2 expression. J Cell Mol Medi. 2021;25:10248\u201356. https:\/\/doi.org\/10.1111\/jcmm.16963. [cited 2025 Nov 24].","journal-title":"J Cell Mol Medi"},{"key":"2666_CR134","doi-asserted-by":"publisher","first-page":"113737","DOI":"10.1016\/j.yexcr.2023.113737","volume":"431","author":"X Huang","year":"2023","unstructured":"Huang X, Wu J, Wang Y, Xian Z, Li J, Qiu N, et al. FOXQ1 inhibits breast cancer ferroptosis and progression via the circ_0000643\/miR-153\/SLC7A11 axis. Exp Cell Res. 2023;431:113737. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113737. [cited 2025 Nov 24].","journal-title":"Exp Cell Res"},{"key":"2666_CR135","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1158\/0008-5472.CAN-17-3454","volume":"78","author":"C Mao","year":"2018","unstructured":"Mao C, Wang X, Liu Y, Wang M, Yan B, Jiang Y, et al. A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53. Cancer Res. 2018;78:3484\u201396. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3454. [cited 2025 Nov 24].","journal-title":"Cancer Res"},{"key":"2666_CR136","doi-asserted-by":"publisher","unstructured":"Tong X, Yu Z, Xing J, Liu H, Zhou S, Huang Y et al. LncRNA HCP5-encoded protein regulates ferroptosis to promote the progression of triple-negative breast cancer. Cancers. 2023;15:1880. https:\/\/doi.org\/10.3390\/cancers15061880. Cited 24 Nov 2025.","DOI":"10.3390\/cancers15061880"},{"key":"2666_CR137","doi-asserted-by":"publisher","unstructured":"Li J, Li P-T, Wu W, Ding B-N, Wen Y-G, Cai H-L et al. POU2F2-mediated upregulation of lncRNA PTPRG-AS1 inhibits ferroptosis in breast cancer via miR-376c-3p\/SLC7A11 axis. Epigenomics. 2024;16:215\u201331. https:\/\/doi.org\/10.2217\/epi-2023-0100. Cited 24 Nov 2025.","DOI":"10.2217\/epi-2023-0100"},{"key":"2666_CR138","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s11427-023-2425-2","volume":"67","author":"X Fan","year":"2024","unstructured":"Fan X, Liu F, Wang X, Wang Y, Chen Y, Shi C, et al. LncFASA promotes cancer ferroptosis via modulating PRDX1 phase separation. Sci China Life Sci. 2024;67:488\u2013503. https:\/\/doi.org\/10.1007\/s11427-023-2425-2. [cited 2025 Nov 24].","journal-title":"Sci China Life Sci"},{"key":"2666_CR139","doi-asserted-by":"publisher","unstructured":"Hou Y, Cai S, Yu S, Lin H. Metformin induces ferroptosis by targeting miR-324-3p\/GPX4 axis in breast cancer. ABBS. 2021;53:333\u201341. https:\/\/doi.org\/10.1093\/abbs\/gmaa180. Cited 24 Nov 2025.","DOI":"10.1093\/abbs\/gmaa180"},{"key":"2666_CR140","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.canlet.2021.09.033","volume":"522","author":"P Yadav","year":"2021","unstructured":"Yadav P, Sharma P, Sundaram S, Venkatraman G, Bera AK, Karunagaran D. SLC7A11\/ xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells. Cancer Lett. 2021;522:211\u201324. https:\/\/doi.org\/10.1016\/j.canlet.2021.09.033. [cited 2025 Nov 24].","journal-title":"Cancer Lett"},{"key":"2666_CR141","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/cac2.12275","volume":"42","author":"X Zhang","year":"2022","unstructured":"Zhang X, Xu Y, Ma L, Yu K, Niu Y, Xu X, et al. Essential roles of exosome and circRNA_101093 on ferroptosis desensitization in lung adenocarcinoma. Cancer Commun. 2022;42:287\u2013313. https:\/\/doi.org\/10.1002\/cac2.12275. [cited 2025 Nov 24].","journal-title":"Cancer Commun"},{"key":"2666_CR142","doi-asserted-by":"publisher","first-page":"366","DOI":"10.21037\/tlcr-22-138","volume":"11","author":"C-F Pan","year":"2022","unstructured":"Pan C-F, Wei K, Ma Z-J, He Y-Z, Huang J-J, Guo Z-Z, et al. CircP4HB regulates ferroptosis via SLC7A11-mediated glutathione synthesis in lung adenocarcinoma. Transl Lung Cancer Res. 2022;11:366\u201380. https:\/\/doi.org\/10.21037\/tlcr-22-138. [cited 2025 Nov 24].","journal-title":"Transl Lung Cancer Res"},{"key":"2666_CR143","doi-asserted-by":"publisher","first-page":"743505","DOI":"10.3389\/fgene.2021.743505","volume":"12","author":"W Shanshan","year":"2021","unstructured":"Shanshan W, Hongying M, Jingjing F, Yiming Y, Yu R, Rui Y. CircDTL Functions as an Oncogene and Regulates Both Apoptosis and Ferroptosis in Non-small Cell Lung Cancer Cells. Front Genet. 2021;12:743505. https:\/\/doi.org\/10.3389\/fgene.2021.743505. [cited 2025 Nov 24].","journal-title":"Front Genet"},{"key":"2666_CR144","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1080\/15384101.2022.2154543","volume":"22","author":"B Liu","year":"2023","unstructured":"Liu B, Ma H, Liu X, Xing W. CircSCN8A suppresses malignant progression and induces ferroptosis in non-small cell lung cancer by regulating miR-1290\/ACSL4 axis. Cell Cycle. 2023;22:758\u201376. https:\/\/doi.org\/10.1080\/15384101.2022.2154543. [cited 2025 Nov 24].","journal-title":"Cell Cycle"},{"key":"2666_CR145","doi-asserted-by":"publisher","unstructured":"Fu H, Zhao Q. CircSCUBE3 promoted ferroptosis to inhibit lung adenocarcinoma progression. Cell Mol Biol (Noisy-le-grand). 2020;70:161\u20138. https:\/\/doi.org\/10.14715\/cmb\/2024.70.2.23. Cited 24 Nov 2025.","DOI":"10.14715\/cmb\/2024.70.2.23"},{"key":"2666_CR146","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s12033-024-01059-z","volume":"67","author":"Z Li","year":"2025","unstructured":"Li Z, Fan M, Zhou Z, Sang X. Circ_0082374 Promotes the Tumorigenesis and Suppresses Ferroptosis in Non-small Cell Lung Cancer by Up-Regulating GPX4 Through Sequestering miR-491-5p. Mol Biotechnol. 2025;67:484\u201395. https:\/\/doi.org\/10.1007\/s12033-024-01059-z. [cited 2025 Nov 24].","journal-title":"Mol Biotechnol"},{"key":"2666_CR147","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.7150\/jca.65017","volume":"13","author":"N Zhang","year":"2022","unstructured":"Zhang N, Huang J, Xu M, Wang Y. LncRNA T-UCR Uc.339\/miR-339\/SLC7A11 Axis Regulates the Metastasis of Ferroptosis-Induced Lung Adenocarcinoma. J Cancer. 2022;13:1945\u201357. https:\/\/doi.org\/10.7150\/jca.65017. [cited 2025 Nov 24].","journal-title":"J Cancer"},{"key":"2666_CR148","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bioactmat.2021.11.013","volume":"13","author":"R Zhang","year":"2022","unstructured":"Zhang R, Pan T, Xiang Y, Zhang M, Xie H, Liang Z, et al. Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19\/miR-19b-3p\/FTH1 axis. Bioactive Mater. 2022;13:23\u201336. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.11.013. [cited 2025 Nov 24].","journal-title":"Bioactive Mater"},{"key":"2666_CR149","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41418-019-0304-y","volume":"26","author":"M Wang","year":"2019","unstructured":"Wang M, Mao C, Ouyang L, Liu Y, Lai W, Liu N, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Differ. 2019;26:2329\u201343. https:\/\/doi.org\/10.1038\/s41418-019-0304-y. [cited 2025 Nov 24].","journal-title":"Cell Death Differ"},{"key":"2666_CR150","doi-asserted-by":"publisher","unstructured":"Gai C, Liu C, Wu X, Yu M, Zheng J, Zhang W et al. MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p\/NRF2 axis in non-small cell lung cancer cells. Cell Death Dis. 2020;11:751. https:\/\/doi.org\/10.1038\/s41419-020-02939-3.\u00a0Cited 24 Nov 2025.","DOI":"10.1038\/s41419-020-02939-3"},{"key":"2666_CR151","doi-asserted-by":"publisher","first-page":"793732","DOI":"10.3389\/fmolb.2021.793732","volume":"8","author":"X Jiang","year":"2022","unstructured":"Jiang X, Yuan Y, Tang L, Wang J, Zhang D, Duan L. Systematic Analysis and Validation of the Prognosis, Immunological Role and Biology Function of the Ferroptosis-Related lncRNA GSEC\/miRNA-101-3p\/CISD1 Axis in Lung Adenocarcinoma. Front Mol Biosci. 2022;8:793732. https:\/\/doi.org\/10.3389\/fmolb.2021.793732. [cited 2025 Nov 24].","journal-title":"Front Mol Biosci"},{"key":"2666_CR152","doi-asserted-by":"publisher","unstructured":"Chen H, Wang L, Liu J, Wan Z, Zhou L, Liao H et al. LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2\/NAMPT axis. Cancer Biol Ther. 2023;24:2223377. https:\/\/doi.org\/10.1080\/15384047.2023.2223377. Cited 24 Nov 2025.","DOI":"10.1080\/15384047.2023.2223377"},{"key":"2666_CR153","doi-asserted-by":"publisher","unstructured":"Xu C, Jiang Z-B, Shao L, Zhao Z-M, Fan X-X, Sui X et al. \u03b2-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer. Pharmacol Res. 2023;191:106739. https:\/\/doi.org\/10.1016\/j.phrs.2023.106739.\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.phrs.2023.106739"},{"key":"2666_CR154","doi-asserted-by":"publisher","unstructured":"Gao G-B, Chen L, Pan J-F, Lei T, Cai X, Hao Z et al. LncRNA RGMB-AS1 inhibits HMOX1 ubiquitination and NAA10 activation to induce ferroptosis in non-small cell lung cancer. Cancer Lett. 2024;590:216826. https:\/\/doi.org\/10.1016\/j.canlet.2024.216826. Cited 24 Nov 2025.","DOI":"10.1016\/j.canlet.2024.216826"},{"key":"2666_CR155","doi-asserted-by":"publisher","unstructured":"Lu X, Kang N, Ling X, Pan M, Du W, Gao S. MiR-27a-3p promotes non-small cell lung cancer through SLC7A11-mediated-ferroptosis. Front Oncol. 2022;11:759346. https:\/\/doi.org\/10.3389\/fonc.2021.759346. Cited 24 Nov 2025.","DOI":"10.3389\/fonc.2021.759346"},{"key":"2666_CR156","doi-asserted-by":"publisher","first-page":"119399","DOI":"10.1016\/j.lfs.2021.119399","volume":"276","author":"Z Song","year":"2021","unstructured":"Song Z, Jia G, Ma P, Cang S. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis. Life Sci. 2021;276:119399. https:\/\/doi.org\/10.1016\/j.lfs.2021.119399. [cited 2025 Nov 24].","journal-title":"Life Sci"},{"key":"2666_CR157","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41598-017-00913-2","volume":"7","author":"J Ren","year":"2017","unstructured":"Ren J, Ding L, Xu Q, Shi G, Li X, Li X, et al. LF-MF inhibits iron metabolism and suppresses lung cancer through activation of P53-miR-34a-E2F1\/E2F3 pathway. Sci Rep. 2017;7:749. https:\/\/doi.org\/10.1038\/s41598-017-00913-2. [cited 2025 Nov 24].","journal-title":"Sci Rep"},{"key":"2666_CR158","doi-asserted-by":"publisher","unstructured":"Deng S, Wu D, Li L, Liu T, Zhang T, Li J et al. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549. Biochem Biophys Res Commun. 2021;549:54\u201360. https:\/\/doi.org\/10.1016\/j.bbrc.2021.02.077. Cited 24 Nov 2025.","DOI":"10.1016\/j.bbrc.2021.02.077"},{"key":"2666_CR159","doi-asserted-by":"publisher","first-page":"104777","DOI":"10.1016\/j.jprot.2022.104777","volume":"274","author":"B Han","year":"2023","unstructured":"Han B, Liu Y, Zhang Q, Liang L. Propofol decreases cisplatin resistance of non-small cell lung cancer by inducing GPX4-mediated ferroptosis through the miR-744-5p\/miR-615-3p axis. J Proteom. 2023;274:104777. https:\/\/doi.org\/10.1016\/j.jprot.2022.104777. [cited 2025 Nov 24].","journal-title":"J Proteom"},{"key":"2666_CR160","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1093\/nar\/gkx1248","volume":"46","author":"JJ Chan","year":"2018","unstructured":"Chan JJ, Kwok ZH, Chew XH, Zhang B, Liu C, Soong TW, et al. A FTH1 gene:pseudogene:microRNA network regulates tumorigenesis in prostate cancer. Nucleic Acids Res. 2018;46:1998\u20132011. https:\/\/doi.org\/10.1093\/nar\/gkx1248. [cited 2025 Nov 24].","journal-title":"Nucleic Acids Res"},{"key":"2666_CR161","doi-asserted-by":"publisher","unstructured":"Jiang X, Guo S, Xu M, Ma B, Liu R, Xu Y et al. TFAP2C-mediated lncRNA PCAT1 inhibits ferroptosis in docetaxel-resistant prostate cancer through c-Myc\/miR-25-3p\/SLC7A11 signaling. Front Oncol. 2022;12:862015. https:\/\/doi.org\/10.3389\/fonc.2022.862015. Cited 24 Nov 2025.","DOI":"10.3389\/fonc.2022.862015"},{"key":"2666_CR162","doi-asserted-by":"publisher","unstructured":"Xu W, Ding J, Li B, Sun T, You X, He Q et al. Effects of icariin and curcumol on autophagy, ferroptosis, and lipid metabolism based on miR-7\/m\u2010TOR\/SREBP1 pathway on prostate cancer. BioFactors. 2023;49:438\u201356. https:\/\/doi.org\/10.1002\/biof.1927. Cited 24 Nov 2025.","DOI":"10.1002\/biof.1927"},{"key":"2666_CR163","doi-asserted-by":"publisher","unstructured":"Liu Y-P, Qiu Z-Z, Li X-H, Li E-Y. Propofol induces ferroptosis and inhibits malignant phenotypes of gastric cancer cells by regulating miR-125b-5p\/STAT3 axis. WJGO. 2021;13:2114\u201328. https:\/\/doi.org\/10.4251\/wjgo.v13.i12.2114. Cited 24 Nov 2025.","DOI":"10.4251\/wjgo.v13.i12.2114"},{"key":"2666_CR164","doi-asserted-by":"publisher","first-page":"16970","DOI":"10.1038\/s41598-019-53174-6","volume":"9","author":"A Gomaa","year":"2019","unstructured":"Gomaa A, Peng D, Chen Z, Soutto M, Abouelezz K, Corvalan A, et al. Epigenetic regulation of AURKA by miR-4715-3p in upper gastrointestinal cancers. Sci Rep. 2019;9:16970. https:\/\/doi.org\/10.1038\/s41598-019-53174-6. [cited 2025 Nov 24].","journal-title":"Sci Rep"},{"key":"2666_CR165","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D, et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19:43. https:\/\/doi.org\/10.1186\/s12943-020-01168-8. [cited 2025 Nov 24].","journal-title":"Mol Cancer"},{"key":"2666_CR166","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s13287-021-02394-7","volume":"12","author":"H Ni","year":"2021","unstructured":"Ni H, Qin H, Sun C, Liu Y, Ruan G, Guo Q, et al. MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis. Stem Cell Res Ther. 2021;12:325. https:\/\/doi.org\/10.1186\/s13287-021-02394-7. [cited 2025 Nov 24].","journal-title":"Stem Cell Res Ther"},{"key":"2666_CR167","doi-asserted-by":"publisher","first-page":"681338","DOI":"10.3389\/fphar.2021.681338","volume":"12","author":"S-H Mao","year":"2021","unstructured":"Mao S-H, Zhu C-H, Nie Y, Yu J, Wang L. Levobupivacaine Induces Ferroptosis by miR-489-3p\/SLC7A11 Signaling in Gastric Cancer. Front Pharmacol. 2021;12:681338. https:\/\/doi.org\/10.3389\/fphar.2021.681338. [cited 2025 Nov 24].","journal-title":"Front Pharmacol"},{"key":"2666_CR168","doi-asserted-by":"publisher","unstructured":"Shao C-J, Zhou H-L, Gao X-Z, Xu C-F. Downregulation of miR-221\u20133p promotes the ferroptosis in gastric cancer cells via upregulation of ATF3 to mediate the transcription inhibition of GPX4 and HRD1.Transl Oncol. 2023;32:101649. https:\/\/doi.org\/10.1016\/j.tranon.2023.101649. Cited 24 Nov 2025.","DOI":"10.1016\/j.tranon.2023.101649"},{"key":"2666_CR169","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jare.2021.10.001","volume":"37","author":"H Yang","year":"2022","unstructured":"Yang H, Hu Y, Weng M, Liu X, Wan P, Hu Y, et al. Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer. J Adv Res. 2022;37:91\u2013106. https:\/\/doi.org\/10.1016\/j.jare.2021.10.001. [cited 2025 Nov 24].","journal-title":"J Adv Res"},{"key":"2666_CR170","doi-asserted-by":"publisher","unstructured":"Huang G, Xiang Z, Wu H, He Q, Dou R, Lin Z et al. The lncRNA BDNF-AS\/WDR5\/FBXW7 axis mediates ferroptosis in gastric cancer peritoneal metastasis by regulating VDAC3 ubiquitination. Int J Biol Sci. 2022;18:1415\u201333. https:\/\/doi.org\/10.7150\/ijbs.69454. Cited 24 Nov 2025.","DOI":"10.7150\/ijbs.69454"},{"key":"2666_CR171","doi-asserted-by":"publisher","unstructured":"Lin Z, Song J, Gao Y, Huang S, Dou R, Zhong P et al. Hypoxia-induced HIF-1\u03b1\/lncRNA-PMAN inhibits ferroptosis by promoting the cytoplasmic translocation of ELAVL1 in peritoneal dissemination from gastric cancer. Redox Biol. 2022;52:102312. https:\/\/doi.org\/10.1016\/j.redox.2022.102312. Cited 24 Nov 2025.","DOI":"10.1016\/j.redox.2022.102312"},{"key":"2666_CR172","doi-asserted-by":"publisher","unstructured":"Qu X, Liu B, Wang L, Liu L, Zhao W, Liu C et al. Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer. Drug Resist Updates. 2023;68:100936. https:\/\/doi.org\/10.1016\/j.drup.2023.100936. Cited 24 Nov 2025.","DOI":"10.1016\/j.drup.2023.100936"},{"key":"2666_CR173","doi-asserted-by":"publisher","unstructured":"Wang J, Jia Q, Jiang S, Lu W, Ning H. POU6F1 promotes ferroptosis by increasing lncRNA-CASC2 transcription to regulate SOCS2\/SLC7A11 signaling in gastric cancer. Cell Biol Toxicol. 2024;40:3. https:\/\/doi.org\/10.1007\/s10565-024-09843-y. Cited 24 Nov 2025.","DOI":"10.1007\/s10565-024-09843-y"},{"key":"2666_CR174","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/jgh.16402","volume":"39","author":"X Dong","year":"2024","unstructured":"Dong X, Chen X, Zhao Y, Wu Q, Ren Y. CircTMEM87A promotes the tumorigenesis of gastric cancer by regulating the miR-1276\/SLC7A11 axis. J Gastro Hepatol. 2024;39:121\u201332. https:\/\/doi.org\/10.1111\/jgh.16402. [cited 2025 Nov 24].","journal-title":"J Gastro Hepatol"},{"key":"2666_CR175","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/tox.23668","volume":"38","author":"J Liu","year":"2023","unstructured":"Liu J, Yang H, Deng J, Jiang R, Meng E, Wu H. CircRPPH1 promotes the stemness of gastric cancer cells by targeting miR-375\/SLC7A11 axis. Environ Toxicol. 2023;38:115\u201325. https:\/\/doi.org\/10.1002\/tox.23668. [cited 2025 Nov 24].","journal-title":"Environ Toxicol"},{"key":"2666_CR176","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1002\/jcp.31093","volume":"238","author":"Z Shang","year":"2023","unstructured":"Shang Z, Luo Z, Wang Y, Liu Q, Xin Y, Zhang M, et al. CircHIPK3 contributes to cisplatin resistance in gastric cancer by blocking autophagy-dependent ferroptosis. J Cell Physiol. 2023;238:2407\u201324. https:\/\/doi.org\/10.1002\/jcp.31093. [cited 2025 Nov 24].","journal-title":"J Cell Physiol"},{"key":"2666_CR177","doi-asserted-by":"publisher","unstructured":"Gao X, Wang X. Dexmedetomidine promotes ferroptotic cell death in gastric cancer via hsa_circ_0008035\/ miR -302a\/ E2F7 axis. Kaohsiung J Med Sci. 2023;39:390\u2013403. https:\/\/doi.org\/10.1002\/kjm2.12650. Cited 24 Nov 2025.","DOI":"10.1002\/kjm2.12650"},{"key":"2666_CR178","doi-asserted-by":"publisher","unstructured":"Zhu J-H, De Mello RA, Yan Q-L, Wang J-W, Chen Y, Ye Q-H et al. MiR-139-5p\/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K\/Akt signaling pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2020;1866:165747. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165747.\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.bbadis.2020.165747"},{"key":"2666_CR179","doi-asserted-by":"publisher","unstructured":"Qi R, Bai Y, Li K, Liu N, Xu Y, Dal E et al. Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs. Drug Resistance Updates. 2023;68:100960. https:\/\/doi.org\/10.1016\/j.drup.2023.100960. Cited 24 Nov 2025.","DOI":"10.1016\/j.drup.2023.100960"},{"key":"2666_CR180","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1158\/1541-7786.MCR-22-0024","volume":"20","author":"X Qiu","year":"2022","unstructured":"Qiu X, Shi Q, Zhang X, Shi X, Jiang H, Qin S. LncRNA A2M-AS1 Promotes Ferroptosis in Pancreatic Cancer via Interacting With PCBP3. Mol Cancer Res. 2022;20:1636\u201345. https:\/\/doi.org\/10.1158\/1541-7786.MCR-22-0024. [cited 2025 Nov 24].","journal-title":"Mol Cancer Res"},{"key":"2666_CR181","doi-asserted-by":"publisher","unstructured":"Li H, Wei Y, Wang J, Yao J, Zhang C, Yu C et al. Long noncoding RNA LINC00578 inhibits ferroptosis in pancreatic cancer via regulating SLC7A11 ubiquitination. Oxid Med Cell Longev. 2023;2023:1\u201317. https:\/\/doi.org\/10.1155\/2023\/1744102.\u00a0Cited 24 Nov 202.","DOI":"10.1155\/2023\/1744102"},{"key":"2666_CR182","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10142-024-01329-8","volume":"24","author":"Y Xiong","year":"2024","unstructured":"Xiong Y, Kong X, Tu S, Xin W, Wei Y, Yi S, et al. LINC02086 inhibits ferroptosis and promotes malignant phenotypes of pancreatic cancer via miR-342-3p\/CA9 axis. Funct Integr Genomics. 2024;24:49. https:\/\/doi.org\/10.1007\/s10142-024-01329-8. [cited 2025 Nov 24].","journal-title":"Funct Integr Genomics"},{"key":"2666_CR183","doi-asserted-by":"publisher","unstructured":"Zhu J, Yu Z, Wang X, Zhang J, Chen Y, Chen K et al. LncRNA MACC1-AS1 induces gemcitabine resistance in pancreatic cancer cells through suppressing ferroptosis. Cell Death Discov. 2024;10:101. https:\/\/doi.org\/10.1038\/s41420-024-01866-y. Cited 24 Nov 2025.","DOI":"10.1038\/s41420-024-01866-y"},{"key":"2666_CR184","doi-asserted-by":"publisher","unstructured":"Zheng S, Hu L, Song Q, Shan Y, Yin G, Zhu H et al. miR-545 promotes colorectal cancer by inhibiting transferring in the non-normal ferroptosis signaling. Aging. 2021;13:26137\u201347. https:\/\/doi.org\/10.18632\/aging.203801. Cited 24 Nov 2025.","DOI":"10.18632\/aging.203801"},{"key":"2666_CR185","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/mc.23367","volume":"61","author":"L Liu","year":"2022","unstructured":"Liu L, Yao H, Zhou X, Chen J, Chen G, Shi X, et al. MiR-15a\u20103p regulates ferroptosis via targeting glutathione peroxidase GPX4 in colorectal cancer. Mol Carcinog. 2022;61:301\u201310. https:\/\/doi.org\/10.1002\/mc.23367. [cited 2025 Nov 24].","journal-title":"Mol Carcinog"},{"key":"2666_CR186","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41420-021-00659-x","volume":"7","author":"Y Yang","year":"2021","unstructured":"Yang Y, Lin Z, Han Z, Wu Z, Hua J, Zhong R, et al. miR-539 activates the SAPK\/JNK signaling pathway to promote ferropotosis in colorectal cancer by directly targeting TIPE. Cell Death Discov. 2021;7:272. https:\/\/doi.org\/10.1038\/s41420-021-00659-x. [cited 2025 Nov 24].","journal-title":"Cell Death Discov"},{"key":"2666_CR187","doi-asserted-by":"publisher","unstructured":"Martino E, Balestrieri A, Aragona F, Bifulco G, Mele L, Campanile G et al. MiR-148a-3p promotes colorectal cancer cell ferroptosis by targeting SLC7A11. Cancers. 2023;15:4342. https:\/\/doi.org\/10.3390\/cancers15174342. Cited 24 Nov 2025.","DOI":"10.3390\/cancers15174342"},{"key":"2666_CR188","doi-asserted-by":"publisher","first-page":"e752","DOI":"10.1002\/ctm2.752","volume":"12","author":"Y Luo","year":"2022","unstructured":"Luo Y, Huang S, Wei J, Zhou H, Wang W, Yang J, et al. Long noncoding RNA LINC01606 protects colon cancer cells from ferroptotic cell death and promotes stemness by SCD1\u2013Wnt\/\u03b2-catenin\u2013TFE3 feedback loop signalling. Clin Translational Med. 2022;12:e752. https:\/\/doi.org\/10.1002\/ctm2.752. [cited 2025 Nov 24].","journal-title":"Clin Translational Med"},{"key":"2666_CR189","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1007\/s12094-023-03193-7","volume":"25","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Ye B, Lin Y, Liu W, Deng J, Ji W. LncRNA OTUD6B-AS1 overexpression promoted GPX4-mediated ferroptosis to suppress radioresistance in colorectal cancer. Clin Transl Oncol. 2023;25:3217\u201329. https:\/\/doi.org\/10.1007\/s12094-023-03193-7. [cited 2025 Nov 24].","journal-title":"Clin Transl Oncol"},{"key":"2666_CR190","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41419-022-05192-y","volume":"13","author":"Y Han","year":"2023","unstructured":"Han Y, Gao X, Wu N, Jin Y, Zhou H, Wang W, et al. Long noncoding RNA LINC00239 inhibits ferroptosis in colorectal cancer by binding to Keap1 to stabilize Nrf2. Cell Death Dis. 2023;13:742. https:\/\/doi.org\/10.1038\/s41419-022-05192-y. [cited 2025 Nov 24].","journal-title":"Cell Death Dis"},{"key":"2666_CR191","doi-asserted-by":"publisher","first-page":"e13541","DOI":"10.1111\/eci.13541","volume":"51","author":"Y Wang","year":"2021","unstructured":"Wang Y, Chen H, Wei X. Circ_0007142 downregulates miR-874\u20103p\u2010mediated GDPD5 on colorectal cancer cells. Eur J Clin Invest. 2021;51:e13541. https:\/\/doi.org\/10.1111\/eci.13541. [cited 2025 Nov 24].","journal-title":"Eur J Clin Invest"},{"key":"2666_CR192","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/tox.23670","volume":"38","author":"Q Li","year":"2023","unstructured":"Li Q, Li K, Guo Q, Yang T. CircRNA circSTIL inhibits ferroptosis in colorectal cancer via miR-431\/SLC7A11 axis. Environ Toxicol. 2023;38:981\u20139. https:\/\/doi.org\/10.1002\/tox.23670. [cited 2025 Nov 24].","journal-title":"Environ Toxicol"},{"key":"2666_CR193","doi-asserted-by":"publisher","unstructured":"Long F, Zhong C, Long Q, Zhu K, Wang J, Yu Y et al. Circular RNA RHBDD1 regulates tumorigenicity and ferroptosis in colorectal cancer by mediating the ELAVL1\/SCD mRNA interaction. Cancer Gene Ther. 2024;31:237\u201349. https:\/\/doi.org\/10.1038\/s41417-023-00698-9. Cited 24 Nov 2025.","DOI":"10.1038\/s41417-023-00698-9"},{"key":"2666_CR194","doi-asserted-by":"publisher","unstructured":"Zhou L, Zhang Q, Cheng J, Shen X, Li J, Chen M et al. LncRNA SNHG1 upregulates FANCD2 and G6PD to suppress ferroptosis by sponging miR-199a-5p\/3p in hepatocellular carcinoma. DD&T. 2023;17:248\u201356. https:\/\/doi.org\/10.5582\/ddt.2023.01035. Cited 24 Nov 2025.","DOI":"10.5582\/ddt.2023.01035"},{"key":"2666_CR195","doi-asserted-by":"publisher","unstructured":"Shi Z, Li Z, Jin B, Ye W, Wang L, Zhang S et al. Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation. Clin Translational Med. 2023;13:e1300. https:\/\/doi.org\/10.1002\/ctm2.1300. Cited 24 Nov 2025.","DOI":"10.1002\/ctm2.1300"},{"key":"2666_CR196","doi-asserted-by":"publisher","unstructured":"He G-N, Bao N-R, Wang S, Xi M, Zhang T-H, Chen F-S. Ketamine induces ferroptosis of liver cancer cells by targeting lncRNA PVT1\/miR-214-3p\/GPX4. DDDT. 2021;15:3965\u201378. https:\/\/doi.org\/10.2147\/DDDT.S332847. Cited\u00a0 24 Nov 2025.","DOI":"10.2147\/DDDT.S332847"},{"key":"2666_CR197","doi-asserted-by":"publisher","unstructured":"Guan L, Wang F, Wang M, Han S, Cui Z, Xi S et al. Downregulation of HULC induces ferroptosis in hepatocellular carcinoma via targeting of the miR-3200\u20105p\/ATF4 axis. Oxid Med Cell Longev. 2022;2022:9613095. https:\/\/doi.org\/10.1155\/2022\/9613095.\u00a0Cited 24 Nov 2025.","DOI":"10.1155\/2022\/9613095"},{"key":"2666_CR198","doi-asserted-by":"publisher","unstructured":"Kang X, Huo Y, Jia S, He F, Li H, Zhou Q et al. Silenced LINC01134 enhances oxaliplatin sensitivity by facilitating ferroptosis through GPX4 in hepatocarcinoma. Front Oncol. 2023;12:939605. https:\/\/doi.org\/10.3389\/fonc.2022.939605. Cited 24 Nov 2025.","DOI":"10.3389\/fonc.2022.939605"},{"key":"2666_CR199","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.7150\/jca.89993","volume":"15","author":"Q Man","year":"2024","unstructured":"Man Q, Zhang G, Chen X, Na SR, Bai S, Zhi H, et al. EPS15-AS1 Inhibits AKR1B1 Expression to Enhance Ferroptosis in Hepatocellular Carcinoma Cells. J Cancer. 2024;15:1030\u201340. https:\/\/doi.org\/10.7150\/jca.89993. [cited 2025 Nov 24].","journal-title":"J Cancer"},{"key":"2666_CR200","doi-asserted-by":"publisher","unstructured":"Lu Y, Chan Y-T, Tan H-Y, Zhang C, Guo W, Xu Y et al. Epigenetic regulation of ferroptosis via ETS1\/miR-23a-3p\/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma. J Exp Clin Cancer Res. 2022;41:3. https:\/\/doi.org\/10.1186\/s13046-021-02208-x. Cited 24 Nov 2025.","DOI":"10.1186\/s13046-021-02208-x"},{"key":"2666_CR201","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1002\/jcp.29496","volume":"235","author":"T Bai","year":"2020","unstructured":"Bai T, Liang R, Zhu R, Wang W, Zhou L, Sun Y. MicroRNA-214\u20103p enhances erastin\u2010induced ferroptosis by targeting ATF4 in hepatoma cells. J Cell Physiol. 2020;235:5637\u201348. https:\/\/doi.org\/10.1002\/jcp.29496. [cited 2025 Nov 24].","journal-title":"J Cell Physiol"},{"key":"2666_CR202","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41420-020-00306-x","volume":"6","author":"Z Liu","year":"2022","unstructured":"Liu Z, Wang Q, Wang X, Xu Z, Wei X, Li J. Circular RNA cIARS regulates ferroptosis in HCC cells through interacting with RNA binding protein ALKBH5. Cell Death Discov. 2022;6:72. https:\/\/doi.org\/10.1038\/s41420-020-00306-x. [cited 2025 Nov 24].","journal-title":"Cell Death Discov"},{"key":"2666_CR203","doi-asserted-by":"publisher","unstructured":"Zhai H, Zhong S, Wu R, Mo Z, Zheng S, Xue J et al. Suppressing circIDE\/miR-19b-3p\/RBMS1 axis exhibits promoting-tumour activity through upregulating GPX4 to diminish ferroptosis in hepatocellular carcinoma. Epigenetics. 2023;18:2192438. https:\/\/doi.org\/10.1080\/15592294.2023.2192438. Cited 24 Nov 2025.","DOI":"10.1080\/15592294.2023.2192438"},{"key":"2666_CR204","doi-asserted-by":"publisher","unstructured":"Tan Y-R, Jiang B-H, Feng W-J, He Z-L, Jiang Y-L, Xun Y et al. Circ0060467 sponges miR-6805 to promote hepatocellular carcinoma progression through regulating AIFM2 and GPX4 expression. Aging. 2024;16:1796\u2013807. https:\/\/doi.org\/10.18632\/aging.205460.\u00a0Cited 24 Nov 2025.","DOI":"10.18632\/aging.205460"},{"key":"2666_CR205","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/s41419-022-05412-5","volume":"13","author":"S Lei","year":"2022","unstructured":"Lei S, Cao W, Zeng Z, Zhang Z, Jin B, Tian Q, et al. JUND\/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202\/GPX4 axis. Cell Death Dis. 2022;13:967. https:\/\/doi.org\/10.1038\/s41419-022-05412-5. [cited 2025 Nov 24].","journal-title":"Cell Death Dis"},{"key":"2666_CR206","doi-asserted-by":"publisher","unstructured":"Wu P, Li C, Ye D, mei, Yu K, Li Y, Tang H et al. Circular RNA circEPSTI1 accelerates cervical cancer progression via miR-375\/409-3P\/515-5p-SLC7A11 axis. Aging. 2021;13:4663\u201373. https:\/\/doi.org\/10.18632\/aging.202518. Cited 24 Nov 2025.","DOI":"10.18632\/aging.202518"},{"key":"2666_CR207","doi-asserted-by":"publisher","unstructured":"Ou R, Lu S, Wang L, Wang Y, Lv M, Li T et al. Circular RNA circLMO1 suppresses cervical cancer growth and metastasis by triggering miR-4291\/ACSL4-mediated ferroptosis. Front Oncol. 2023;12:858598. https:\/\/doi.org\/10.3389\/fonc.2022.858598. Cited 24 Nov 2025.","DOI":"10.3389\/fonc.2022.858598"},{"key":"2666_CR208","doi-asserted-by":"publisher","unstructured":"Xu Z, Chen L, Wang C, Zhang L, Xu W. MicroRNA-1287-5p promotes ferroptosis of osteosarcoma cells through inhibiting GPX4. Free Radical Research. 2021;55:1119\u201329. https:\/\/doi.org\/10.1080\/10715762.2021.2024816.\u00a0Cited 24 Nov 2025.","DOI":"10.1080\/10715762.2021.2024816"},{"key":"2666_CR209","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41417-022-00581-z","volume":"30","author":"L Li","year":"2023","unstructured":"Li L, Zhang Y, Gao Y, Hu Y, Wang R, Wang S, et al. LncSNHG14 promotes nutlin3a resistance by inhibiting ferroptosis via the miR-206 \/SLC7A11 axis in osteosarcoma cells. Cancer Gene Ther. 2023;30:704\u201315. https:\/\/doi.org\/10.1038\/s41417-022-00581-z. [cited 2025 Nov 24].","journal-title":"Cancer Gene Ther"},{"key":"2666_CR210","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12943-023-01804-z","volume":"22","author":"M Jiang","year":"2023","unstructured":"Jiang M, Jike Y, Liu K, Gan F, Zhang K, Xie M, et al. Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1. Mol Cancer. 2023;22:113. https:\/\/doi.org\/10.1186\/s12943-023-01804-z. [cited 2025 Nov 24].","journal-title":"Mol Cancer"},{"key":"2666_CR211","doi-asserted-by":"publisher","first-page":"100490","DOI":"10.1016\/j.jbo.2023.100490","volume":"41","author":"S Xia","year":"2023","unstructured":"Xia S, Liang Y, Shen Y, Zhong W, Ma Y. MAT2A inhibits the ferroptosis in osteosarcoma progression regulated by miR-26b-5p. J Bone Oncol. 2023;41:100490. https:\/\/doi.org\/10.1016\/j.jbo.2023.100490. [cited 2025 Nov 24].","journal-title":"J Bone Oncol"},{"key":"2666_CR212","doi-asserted-by":"publisher","unstructured":"Ma L-L, Liang L, Zhou D, Wang S-W. Tumor suppressor miR-424-5p abrogates ferroptosis in ovarian cancer through targeting ACSL4. neo. 2021;68:165\u201373. https:\/\/doi.org\/10.4149\/neo_2020_200707N705.\u00a0Cited 24 Nov 2025.","DOI":"10.4149\/neo_2020_200707N705"},{"key":"2666_CR213","doi-asserted-by":"publisher","first-page":"102493","DOI":"10.1016\/j.redox.2022.102493","volume":"57","author":"J Zhang","year":"2022","unstructured":"Zhang J, Chen S, Wei S, Cheng S, Shi R, Zhao R, et al. CircRAPGEF5 interacts with RBFOX2 to confer ferroptosis resistance by modulating alternative splicing of TFRC in endometrial cancer. Redox Biology. 2022;57:102493. https:\/\/doi.org\/10.1016\/j.redox.2022.102493. [cited 2025 Nov 24].","journal-title":"Redox Biology"},{"key":"2666_CR214","doi-asserted-by":"publisher","unstructured":"Zhang Z, Li B, Wang Z, Yang L, Peng J, Wang H et al. Novel LncRNA LINC02936 suppresses ferroptosis and promotes tumor progression by interacting with SIX1\/CP axis in endometrial cancer. Int J Biol Sci. 2024;20:1356\u201374. https:\/\/doi.org\/10.7150\/ijbs.86256. Cited 24 Nov 2025.","DOI":"10.7150\/ijbs.86256"},{"key":"2666_CR215","doi-asserted-by":"publisher","first-page":"802124","DOI":"10.3389\/fonc.2021.802124","volume":"11","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Wu H, Wang F, Xu L, Yan Y, Tong X, et al. GPX7 Is Targeted by miR-29b and GPX7 Knockdown Enhances Ferroptosis Induced by Erastin in Glioma. Front Oncol. 2017;11:802124. https:\/\/doi.org\/10.3389\/fonc.2021.802124. [cited 2025 Nov 24].","journal-title":"Front Oncol"},{"key":"2666_CR216","doi-asserted-by":"publisher","unstructured":"Bao C, Zhang J, Xian S-Y, Chen F. MicroRNA-670-3p suppresses ferroptosis of human glioblastoma cells through targeting ACSL4. Free Radical Research. 2021;55:743\u201354. https:\/\/doi.org\/10.1080\/10715762.2021.1962009. Cited 24 Nov 2025.","DOI":"10.1080\/10715762.2021.1962009"},{"key":"2666_CR217","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41420-021-00709-4","volume":"7","author":"Q Chen","year":"2021","unstructured":"Chen Q, Wang W, Wu Z, Chen S, Chen X, Zhuang S, et al. Over-expression of lncRNA TMEM161B-AS1 promotes the malignant biological behavior of glioma cells and the resistance to temozolomide via up-regulating the expression of multiple ferroptosis-related genes by sponging hsa-miR-27a-3p. Cell Death Discov. 2021;7:311. https:\/\/doi.org\/10.1038\/s41420-021-00709-4. [cited 2025 Nov 24].","journal-title":"Cell Death Discov"},{"key":"2666_CR218","doi-asserted-by":"publisher","unstructured":"Luo J, Bai R, Liu Y, Bi H, Shi X, Qu C. Long non-coding RNA ATXN8OS promotes ferroptosis and inhibits the temozolomide-resistance of gliomas through the ADAR\/GLS2 pathway. Brain Res Bull. 2022;186:27\u201337. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.04.005.\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.brainresbull.2022.04.005"},{"key":"2666_CR219","doi-asserted-by":"publisher","first-page":"817737","DOI":"10.3389\/fonc.2022.817737","volume":"12","author":"H Fu","year":"2022","unstructured":"Fu H, Zhang Z, Li D, Lv Q, Chen S, Zhang Z, et al. LncRNA PELATON, a Ferroptosis Suppressor and Prognositic Signature for GBM. Front Oncol. 2022;12:817737. https:\/\/doi.org\/10.3389\/fonc.2022.817737. [cited 2025 Nov 24].","journal-title":"Front Oncol"},{"key":"2666_CR220","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13046-023-02684-3","volume":"42","author":"J Zheng","year":"2023","unstructured":"Zheng J, Zhang Q, Zhao Z, Qiu Y, Zhou Y, Wu Z, et al. Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1. J Exp Clin Cancer Res. 2023;42:127. https:\/\/doi.org\/10.1186\/s13046-023-02684-3. [cited 2025 Nov 24].","journal-title":"J Exp Clin Cancer Res"},{"key":"2666_CR221","doi-asserted-by":"publisher","unstructured":"Zhao J, Yang S, Lv C, Liu Y. Cancer-associated fibroblasts suppressed ferroptosis in glioblastoma via upregulating lncRNA DLEU1. Am J Physiol Cell Physiol. 2023;324:C1039\u201352. https:\/\/doi.org\/10.1152\/ajpcell.00454.2022.\u00a0Cited 24 Nov 2025.","DOI":"10.1152\/ajpcell.00454.2022"},{"key":"2666_CR222","doi-asserted-by":"publisher","unstructured":"Xu L, Wen B, Wu Q, Lu S, Liao J, Mo L et al. Long non-coding RNA KB-1460A1.5 promotes ferroptosis by inhibiting mTOR\/SREBP-1\/SCD1-mediated polyunsaturated fatty acid desaturation in glioma. Carcinog. 2024;45:487\u201399. https:\/\/doi.org\/10.1093\/carcin\/bgae016.\u00a0Cited 24 Nov 2025.","DOI":"10.1093\/carcin\/bgae016"},{"key":"2666_CR223","doi-asserted-by":"publisher","first-page":"841","DOI":"10.7150\/ijbs.66114","volume":"18","author":"S Chen","year":"2022","unstructured":"Chen S, Zhang Z, Zhang B, Huang Q, Liu Y, Qiu Y, et al. CircCDK14 Promotes Tumor Progression and Resists Ferroptosis in Glioma by Regulating PDGFRA. Int J Biol Sci. 2022;18:841\u201357. https:\/\/doi.org\/10.7150\/ijbs.66114. [cited 2025 Nov 24].","journal-title":"Int J Biol Sci"},{"key":"2666_CR224","doi-asserted-by":"publisher","unstructured":"Zhang H-Y, Zhang B-W, Zhang Z-B, Deng Q-J, Circular. RNA TTBK2 regulates cell proliferation, invasion and ferroptosis via miR-761\/ITGB8 axis in glioma. Eur Rev Med Pharmacol Sci. 2020;24:2585\u2013600. https:\/\/doi.org\/10.26355\/eurrev_202003_20528. Cited 24 Nov 2025.","DOI":"10.26355\/eurrev_202003_20528"},{"key":"2666_CR225","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13046-022-02518-8","volume":"41","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhao J, Li R, Liu Y, Zhou L, Wang C, et al. CircLRFN5 inhibits the progression of glioblastoma via PRRX2\/GCH1 mediated ferroptosis. J Exp Clin Cancer Res. 2022;41:307. https:\/\/doi.org\/10.1186\/s13046-022-02518-8. [cited 2025 Nov 24].","journal-title":"J Exp Clin Cancer Res"},{"key":"2666_CR226","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41419-019-1854-0","volume":"10","author":"Y Kong","year":"2022","unstructured":"Kong Y, Hu L, Lu K, Wang Y, Xie Y, Gao L, et al. Ferroportin downregulation promotes cell proliferation by modulating the Nrf2\u2013miR-17-5p axis in multiple myeloma. Cell Death Dis. 2022;10:624. https:\/\/doi.org\/10.1038\/s41419-019-1854-0. [cited 2025 Nov 24].","journal-title":"Cell Death Dis"},{"key":"2666_CR227","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/tox.23126","volume":"36","author":"L Dong","year":"2021","unstructured":"Dong L, Huang J, Zu P, Liu J, Gao X, Du J, et al. CircKDM4C upregulates P53 by sponging hsa-let\u20107b\u20105p to induce ferroptosis in acute myeloid leukemia. Environ Toxicol. 2021;36:1288\u2013302. https:\/\/doi.org\/10.1002\/tox.23126. [cited 2025 Nov 24].","journal-title":"Environ Toxicol"},{"key":"2666_CR228","doi-asserted-by":"publisher","unstructured":"Long F, Lin Z, Long Q, Lu Z, Zhu K, Zhao M et al. CircZBTB46 protects acute myeloid leukemia cells from ferroptotic cell death by upregulating SCD. Cancers. 2023;15:459. https:\/\/doi.org\/10.3390\/cancers15020459.\u00a0Cited 24 Nov 2025.","DOI":"10.3390\/cancers15020459"},{"key":"2666_CR229","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ymthe.2020.09.024","volume":"29","author":"Z Wang","year":"2021","unstructured":"Wang Z, Chen X, Liu N, Shi Y, Liu Y, Ouyang L, et al. A Nuclear Long Non-Coding RNA LINC00618 Accelerates Ferroptosis in a Manner Dependent upon Apoptosis. Mol Therapy. 2021;29:263\u201374. https:\/\/doi.org\/10.1016\/j.ymthe.2020.09.024. [cited 2025 Nov 24].","journal-title":"Mol Therapy"},{"key":"2666_CR230","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1007\/s13577-021-00557-5","volume":"34","author":"Y Liao","year":"2021","unstructured":"Liao Y, Jia X, Ren Y, Deji Z, Gesang Y, Ning N, et al. Suppressive role of microRNA-130b-3p in ferroptosis in melanoma cells correlates with DKK1 inhibition and Nrf2-HO-1 pathway activation. Hum Cell. 2021;34:1532\u201344. https:\/\/doi.org\/10.1007\/s13577-021-00557-5. [cited 2025 Nov 24].","journal-title":"Hum Cell"},{"key":"2666_CR231","doi-asserted-by":"publisher","first-page":"e004381","DOI":"10.1136\/jitc-2021-004381","volume":"10","author":"W Guo","year":"2022","unstructured":"Guo W, Wu Z, Chen J, Guo S, You W, Wang S, et al. Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis. J Immunother Cancer. 2022;10:e004381. https:\/\/doi.org\/10.1136\/jitc-2021-004381. [cited 2025 Nov 24].","journal-title":"J Immunother Cancer"},{"key":"2666_CR232","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41418-017-0053-8","volume":"25","author":"M Luo","year":"2018","unstructured":"Luo M, Wu L, Zhang K, Wang H, Zhang T, Gutierrez L, et al. miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma. Cell Death Differ. 2018;25:1457\u201372. https:\/\/doi.org\/10.1038\/s41418-017-0053-8. [cited 2025 Nov 24].","journal-title":"Cell Death Differ"},{"key":"2666_CR233","doi-asserted-by":"publisher","unstructured":"Zhang K, Wu L, Zhang P, Luo M, Du J, Gao T et al. miR-9 regulates ferroptosis by targeting glutamic\u2010oxaloacetic transaminase GOT1 in melanoma. Mol Carcinog. 2018;57:1566\u201376. https:\/\/doi.org\/10.1002\/mc.22878. Cited 24 Nov 2025.","DOI":"10.1002\/mc.22878"},{"key":"2666_CR234","doi-asserted-by":"publisher","unstructured":"Yang J, Cao X-H, Luan K-F, Huang Y-D, Circular. RNA FNDC3B protects oral squamous cell carcinoma cells from ferroptosis and contributes to the malignant progression by regulating miR-520d-5p\/SLC7A11 axis. Front Oncol. 2021;11:672724. https:\/\/doi.org\/10.3389\/fonc.2021.672724. Cited 24 Nov 2025.","DOI":"10.3389\/fonc.2021.672724"},{"key":"2666_CR235","doi-asserted-by":"publisher","unstructured":"Yao W, Wang J, Meng F, Zhu Z, Jia X, Xu L et al. Circular RNA CircPVT1 inhibits 5-fluorouracil chemosensitivity by regulating ferroptosis through MiR-30a-5p\/FZD3 axis in esophageal cancer cells. Front Oncol. 2021;11:780938. https:\/\/doi.org\/10.3389\/fonc.2021.780938.\u00a0 Cited 24 Nov 2025.","DOI":"10.3389\/fonc.2021.780938"},{"key":"2666_CR236","doi-asserted-by":"publisher","unstructured":"Zhang Y, Tang Q, Huang X-M, Liao D-Z, Circular. RNA circCNOT6L regulates cell development through modulating miR-384\/FN1 axis in esophageal squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 2020;24:3674\u201385. https:\/\/doi.org\/10.26355\/eurrev_202004_20830. Cited 24 Nov 2025.","DOI":"10.26355\/eurrev_202004_20830"},{"key":"2666_CR237","doi-asserted-by":"publisher","unstructured":"Chen W, Fu J, Chen Y, Li Y, Ning L, Huang D et al. Circular RNA circKIF4A facilitates the malignant progression and suppresses ferroptosis by sponging miR-1231 and upregulating GPX4 in papillary thyroid cancer. Aging. 2021;13:16500\u201312. https:\/\/doi.org\/10.18632\/aging.203172.\u00a0Cited 24 Nov 2025.","DOI":"10.18632\/aging.203172"},{"key":"2666_CR238","doi-asserted-by":"publisher","first-page":"670031","DOI":"10.3389\/fendo.2021.670031","volume":"12","author":"H-H Wang","year":"2021","unstructured":"Wang H-H, Ma J-N, Zhan X-R. Circular RNA Circ_0067934 Attenuates Ferroptosis of Thyroid Cancer Cells by miR-545-3p\/SLC7A11 Signaling. Front Endocrinol. 2021;12:670031. https:\/\/doi.org\/10.3389\/fendo.2021.670031. [cited 2025 Nov 24].","journal-title":"Front Endocrinol"},{"key":"2666_CR239","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-022-01615-8","volume":"21","author":"Y Xi","year":"2022","unstructured":"Xi Y, Shen Y, Wu D, Zhang J, Lin C, Wang L, et al. CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p. Mol Cancer. 2022;21:145. https:\/\/doi.org\/10.1186\/s12943-022-01615-8. [cited 2025 Nov 24].","journal-title":"Mol Cancer"},{"key":"2666_CR240","doi-asserted-by":"publisher","first-page":"101697","DOI":"10.1016\/j.redox.2020.101697","volume":"37","author":"J Lee","year":"2020","unstructured":"Lee J, You JH, Kim M-S, Roh J-L. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer. Redox Biology. 2020;37:101697. https:\/\/doi.org\/10.1016\/j.redox.2020.101697. [cited 2025 Nov 24].","journal-title":"Redox Biology"},{"key":"2666_CR241","doi-asserted-by":"publisher","unstructured":"Yu Y, MohamedAl-Sharani H, Zhang B, EZH2\u2010mediated. SLC7A11 upregulation via miR\u2010125b\u20105p represses ferroptosis of TSCC. Oral Diseases. 2023;29:880\u201391. https:\/\/doi.org\/10.1111\/odi.14040. Cited 24 Nov 2025.","DOI":"10.1111\/odi.14040"},{"key":"2666_CR242","doi-asserted-by":"publisher","first-page":"175317","DOI":"10.1016\/j.ejphar.2022.175317","volume":"934","author":"C Pan","year":"2022","unstructured":"Pan C, Chen G, Zhao X, Xu X, Liu J. lncRNA BBOX1-AS1 silencing inhibits esophageal squamous cell cancer progression by promoting ferroptosis via miR-513a-3p\/SLC7A11 axis. Eur J Pharmacol. 2022;934:175317. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175317. [cited 2025 Nov 24].","journal-title":"Eur J Pharmacol"},{"key":"2666_CR243","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s40618-023-02010-w","volume":"46","author":"N Wu","year":"2023","unstructured":"Wu N, Zhu D, Li J, Li X, Zhu Z, Rao Q, et al. CircOMA1 modulates cabergoline resistance by downregulating ferroptosis in prolactinoma. J Endocrinol Invest. 2023;46:1573\u201387. https:\/\/doi.org\/10.1007\/s40618-023-02010-w. [cited 2025 Nov 24].","journal-title":"J Endocrinol Invest"},{"key":"2666_CR244","doi-asserted-by":"publisher","unstructured":"Zhu C, Song Z, Chen Z, Lin T, Lin H, Xu Z et al. MicroRNA-4735-3p facilitates ferroptosis in clear cell renal cell carcinoma by targeting SLC40A1. Anal Cell Pathol. 2022;2022:1\u201312. https:\/\/doi.org\/10.1155\/2022\/4213401.\u00a0Cited 24 Nov 2025.","DOI":"10.1155\/2022\/4213401"},{"key":"2666_CR245","doi-asserted-by":"publisher","unstructured":"Yu R, Zhou Y, Shi S, Wang X, Huang S, Ren Y. Icariside II induces ferroptosis in renal cell carcinoma cells by regulating the miR-324-3p\/GPX4 axis. Phytomedicine. 2022;102:154182. https:\/\/doi.org\/10.1016\/j.phymed.2022.154182.\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.phymed.2022.154182"},{"key":"2666_CR246","doi-asserted-by":"publisher","unstructured":"Li Yze, Zhu HC, Du Y, Zhao H, chao, Wang L. Silencing lncRNA SLC16A1-AS1 induced ferroptosis in renal cell carcinoma through miR-143-3p\/SLC7A11 signaling. Technol Cancer Res Treat. 2022;21:15330338221077803. https:\/\/doi.org\/10.1177\/15330338221077803. Cited 24 Nov 2025.","DOI":"10.1177\/15330338221077803"},{"key":"2666_CR247","doi-asserted-by":"publisher","unstructured":"Luo W, Wang J, Xu W, Ma C, Wan F, Huang Y et al. LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer. Cell Death Dis. 2021;12:1043. https:\/\/doi.org\/10.1038\/s41419-021-04296-1. Cited 24 Nov 2025.","DOI":"10.1038\/s41419-021-04296-1"},{"key":"2666_CR248","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.scib.2021.01.027","volume":"66","author":"L Xiang","year":"2021","unstructured":"Xiang L, Zeng Q, Liu J, Xiao M, He D, Zhang Q, et al. MAFG-AS1\/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis. Sci Bull. 2021;66:1773\u201388. https:\/\/doi.org\/10.1016\/j.scib.2021.01.027. [cited 2025 Nov 24].","journal-title":"Sci Bull"},{"key":"2666_CR249","doi-asserted-by":"publisher","unstructured":"Cao Y, Zou Z, Wu X, Li W, Lu Z, Hu J et al. LUCAT1 inhibits ferroptosis in bladder cancer by regulating the mRNA stability of STAT3. Gene. 2024;894:147974. https:\/\/doi.org\/10.1016\/j.gene.2023.147974. Cited 24 Nov 2025.","DOI":"10.1016\/j.gene.2023.147974"},{"key":"2666_CR250","doi-asserted-by":"publisher","unstructured":"Weller M, Wick W, Aldape K, Brada M, Berger M, Pfister SM et al. Glioma. Nat Rev Dis Primers. 2020;1:15017. https:\/\/doi.org\/10.1038\/nrdp.2015.17.\u00a0\u00a0Cited 24 Nov 2025.","DOI":"10.1038\/nrdp.2015.17"},{"key":"2666_CR251","doi-asserted-by":"publisher","first-page":"817643","DOI":"10.3389\/fcell.2022.817643","volume":"10","author":"J Shi","year":"2020","unstructured":"Shi J, Lai D, Zuo X, Liu D, Chen B, Zheng Y, et al. Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With Glioma. Front Cell Dev Biol. 2020;10:817643. https:\/\/doi.org\/10.3389\/fcell.2022.817643. [cited 2025 Nov 24].","journal-title":"Front Cell Dev Biol"},{"key":"2666_CR252","doi-asserted-by":"publisher","unstructured":"Chow LQM. Head and Neck Cancer. N Engl J Med. 2020;382:60\u201372. https:\/\/doi.org\/10.1056\/NEJMra1715715.\u00a0Cited 24 Nov 2025.","DOI":"10.1056\/NEJMra1715715"},{"key":"2666_CR253","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.\u00a0Cited 24 Nov 2025.","DOI":"10.3322\/caac.21660"},{"key":"2666_CR254","doi-asserted-by":"publisher","first-page":"702","DOI":"10.7150\/ijbs.55552","volume":"17","author":"Y Tang","year":"2021","unstructured":"Tang Y, Li C, Zhang Y-J, Wu Z-H. Ferroptosis-Related Long Non-Coding RNA signature predicts the prognosis of Head and neck squamous cell carcinoma. Int J Biol Sci. 2021;17:702\u201311. https:\/\/doi.org\/10.7150\/ijbs.55552. [cited 2025 Nov 24].","journal-title":"Int J Biol Sci"},{"key":"2666_CR255","doi-asserted-by":"publisher","first-page":"eadf0837","DOI":"10.1126\/sciadv.adf0837","volume":"9","author":"G-H Su","year":"2023","unstructured":"Su G-H, Xiao Y, You C, Zheng R-C, Zhao S, Sun S-Y, et al. Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets. Sci Adv. 2023;9:eadf0837. https:\/\/doi.org\/10.1126\/sciadv.adf0837. [cited 2025 Nov 24].","journal-title":"Sci Adv"},{"key":"2666_CR256","doi-asserted-by":"publisher","first-page":"678877","DOI":"10.3389\/fmolb.2021.678877","volume":"8","author":"K Zhang","year":"2021","unstructured":"Zhang K, Ping L, Du T, Liang G, Huang Y, Li Z, et al. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer. Front Mol Biosci. 2021;8:678877. https:\/\/doi.org\/10.3389\/fmolb.2021.678877. [cited 2025 Nov 24].","journal-title":"Front Mol Biosci"},{"key":"2666_CR257","doi-asserted-by":"publisher","unstructured":"Wei T, Zhu N, Jiang W, Xing X-L. Development and validation of ferroptosis- and immune-related lncRNAs signatures for breast infiltrating duct and lobular carcinoma. Front Oncol. 2022;12:844642. https:\/\/doi.org\/10.3389\/fonc.2022.844642.\u00a0Cited 24 Nov 2025.","DOI":"10.3389\/fonc.2022.844642"},{"key":"2666_CR258","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/2211-5463.13314","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J, Qin C, Zhou Y, Chen Y, Mao M, Yang J. Metformin may induce ferroptosis by inhibiting autophagy via lncRNA H19 in breast cancer. FEBS Open Bio. 2022;12:146\u201353. https:\/\/doi.org\/10.1002\/2211-5463.13314. [cited 2025 Nov 24].","journal-title":"FEBS Open Bio"},{"key":"2666_CR259","doi-asserted-by":"publisher","first-page":"25","DOI":"10.31768\/2312-8852.2017.39(1):25-29","volume":"39","author":"VF Chekhun","year":"2017","unstructured":"Chekhun VF, Lukianova NY, Borikun TV, Zadvorny TV, Mokhir A. Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics. Exp Oncol. 2017;39:25\u20139.","journal-title":"Exp Oncol"},{"key":"2666_CR260","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pharmthera.2015.12.001","volume":"158","author":"G Leon","year":"2016","unstructured":"Leon G, MacDonagh L, Finn SP, Cuffe S, Barr MP. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways. Pharmacol Ther. 2016;158:71\u201390. https:\/\/doi.org\/10.1016\/j.pharmthera.2015.12.001. [cited 2025 Nov 24].","journal-title":"Pharmacol Ther"},{"key":"2666_CR261","doi-asserted-by":"publisher","first-page":"878947","DOI":"10.3389\/fneur.2022.878947","volume":"13","author":"Q Chen","year":"2022","unstructured":"Chen Q, Pan Q, Gao H, Wang Y, Zhong X. miR-17-5p\/HOXA7 Is a Potential Driver for Brain Metastasis of Lung Adenocarcinoma Related to Ferroptosis Revealed by Bioinformatic Analysis. Front Neurol. 2022;13:878947. https:\/\/doi.org\/10.3389\/fneur.2022.878947. [cited 2025 Nov 24].","journal-title":"Front Neurol"},{"key":"2666_CR262","doi-asserted-by":"publisher","unstructured":"Fei X, Hu C, Wang X, Lu C, Chen H, Sun B et al. Construction of a ferroptosis-related long non-coding rna prognostic signature and competing endogenous RNA network in lung adenocarcinoma. Front Cell Dev Biol. 2022;9:751490. https:\/\/doi.org\/10.3389\/fcell.2021.751490. Cited 24 Nov 2025.","DOI":"10.3389\/fcell.2021.751490"},{"key":"2666_CR263","doi-asserted-by":"publisher","first-page":"632","DOI":"10.21037\/tlcr-22-224","volume":"11","author":"N Yao","year":"2022","unstructured":"Yao N, Zuo L, Yan X, Qian J, Sun J, Xu H, et al. Systematic analysis of ferroptosis-related long non-coding RNA predicting prognosis in patients with lung squamous cell carcinoma. Transl Lung Cancer Res. 2022;11:632\u201346. https:\/\/doi.org\/10.21037\/tlcr-22-224. [cited 2025 Nov 24].","journal-title":"Transl Lung Cancer Res"},{"key":"2666_CR264","doi-asserted-by":"publisher","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. The Lancet. 2020;396:635\u201348. https:\/\/doi.org\/10.1016\/S0140-6736(20)31288-5. Cited 24 Nov 2025.","DOI":"10.1016\/S0140-6736(20)31288-5"},{"key":"2666_CR265","doi-asserted-by":"publisher","unstructured":"Li X, Sun Z, Peng G, Xiao Y, Guo J, Wu B et al. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer. Theranostics. 2022;12:620\u201338. https:\/\/doi.org\/10.7150\/thno.60540.\u00a0Cited 24 Nov 2025.","DOI":"10.7150\/thno.60540"},{"key":"2666_CR266","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1186\/s12885-021-08975-2","volume":"21","author":"J Wei","year":"2021","unstructured":"Wei J, Zeng Y, Gao X, Liu T. A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer. BMC Cancer. 2021;21:1221. https:\/\/doi.org\/10.1186\/s12885-021-08975-2. [cited 2025 Nov 24].","journal-title":"BMC Cancer"},{"key":"2666_CR267","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1249290","volume":"2022","author":"Y Cai","year":"2022","unstructured":"Cai Y, Wu S, Jia Y, Pan X, Li C. Potential Key Markers for Predicting the Prognosis of Gastric Adenocarcinoma Based on the Expression of Ferroptosis-Related lncRNA. J Immunol Res. 2022;2022:1\u201317. https:\/\/doi.org\/10.1155\/2022\/1249290. [cited 2025 Nov 24].","journal-title":"J Immunol Res"},{"key":"2666_CR268","doi-asserted-by":"publisher","unstructured":"Ilic M, Ilic I. Epidemiology of pancreatic cancer. WJG. 2016;22:9694. https:\/\/doi.org\/10.3748\/wjg.v22.i44.9694. Cited 24 Nov 2025.","DOI":"10.3748\/wjg.v22.i44.9694"},{"key":"2666_CR269","doi-asserted-by":"publisher","first-page":"937413","DOI":"10.3389\/fphar.2022.937413","volume":"13","author":"P Tan","year":"2024","unstructured":"Tan P, Li M, Liu Z, Li T, Zhao L, Fu W. Glycolysis-Related LINC02432\/Hsa-miR-98\u20135p\/HK2 Axis Inhibits Ferroptosis and Predicts Immune Infiltration, Tumor Mutation Burden, and Drug Sensitivity in Pancreatic Adenocarcinoma. Front Pharmacol. 2024;13:937413. https:\/\/doi.org\/10.3389\/fphar.2022.937413. [cited 2025 Nov 24].","journal-title":"Front Pharmacol"},{"key":"2666_CR270","doi-asserted-by":"publisher","first-page":"819724","DOI":"10.3389\/fcell.2022.819724","volume":"10","author":"D Chen","year":"2022","unstructured":"Chen D, Gao W, Zang L, Zhang X, Li Z, Zhu H, et al. Ferroptosis-Related IncRNAs Are Prognostic Biomarker of Overall Survival in Pancreatic Cancer Patients. Front Cell Dev Biol. 2022;10:819724. https:\/\/doi.org\/10.3389\/fcell.2022.819724. [cited 2025 Nov 24].","journal-title":"Front Cell Dev Biol"},{"key":"2666_CR271","doi-asserted-by":"publisher","first-page":"bbab388","DOI":"10.1093\/bib\/bbab388","volume":"23","author":"R Tang","year":"2022","unstructured":"Tang R, Wu Z, Rong Z, Xu J, Wang W, Zhang B, et al. Ferroptosis-related lncRNA pairs to predict the clinical outcome and molecular characteristics of pancreatic ductal adenocarcinoma. Brief Bioinform. 2022;23:bbab388. https:\/\/doi.org\/10.1093\/bib\/bbab388. [cited 2025 Nov 24].","journal-title":"Brief Bioinform"},{"key":"2666_CR272","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","volume":"15","author":"JP Neoptolemos","year":"2018","unstructured":"Neoptolemos JP, Kleeff J, Michl P, Costello E, Greenhalf W, Palmer DH. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol. 2018;15:333\u201348. https:\/\/doi.org\/10.1038\/s41575-018-0005-x. [cited 2025 Nov 24].","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2666_CR273","doi-asserted-by":"publisher","unstructured":"Yang J, Xu J, Zhang B, Tan Z, Meng Q, Hua J et al. Ferroptosis: at the crossroad of gemcitabine resistance and tumorigenesis in pancreatic cancer. IJMS. 2021;22:10944. https:\/\/doi.org\/10.3390\/ijms222010944. Cited 24 Nov 2025.","DOI":"10.3390\/ijms222010944"},{"key":"2666_CR274","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","volume":"152","author":"D Sia","year":"2017","unstructured":"Sia D, Villanueva A, Friedman SL, Llovet JM. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis. Gastroenterol. 2017;152:745\u201361. https:\/\/doi.org\/10.1053\/j.gastro.2016.11.048. [cited 2025 Nov 24].","journal-title":"Gastroenterol"},{"key":"2666_CR275","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1136\/gutjnl-2022-327909","volume":"72","author":"C Conche","year":"2023","unstructured":"Conche C, Finkelmeier F, Pe\u0161i\u0107 M, Nicolas AM, B\u00f6ttger TW, Kennel KB, et al. Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade. Gut. 2023;72:1774\u201382. https:\/\/doi.org\/10.1136\/gutjnl-2022-327909. [cited 2025 Nov 24].","journal-title":"Gut"},{"key":"2666_CR276","doi-asserted-by":"publisher","first-page":"719175","DOI":"10.3389\/fimmu.2021.719175","volume":"12","author":"Z Xu","year":"2023","unstructured":"Xu Z, Peng B, Liang Q, Chen X, Cai Y, Zeng S, et al. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Front Immunol. 2023;12:719175. https:\/\/doi.org\/10.3389\/fimmu.2021.719175. [cited 2025 Nov 24].","journal-title":"Front Immunol"},{"key":"2666_CR277","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41575-019-0230-y","volume":"17","author":"G Jung","year":"2020","unstructured":"Jung G, Hern\u00e1ndez-Ill\u00e1n E, Moreira L, Balaguer F, Goel A. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol. 2020;17:111\u201330. https:\/\/doi.org\/10.1038\/s41575-019-0230-y. [cited 2025 Nov 24].","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2666_CR278","doi-asserted-by":"publisher","unstructured":"Chen P, Li X, Zhang R, Liu S, Xiang Y, Zhang M et al. Combinative treatment of \u03b2-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation. Theranostics. 2020;10:5107\u201319. https:\/\/doi.org\/10.7150\/thno.44705. Cited 24 Nov 2025.","DOI":"10.7150\/thno.44705"},{"key":"2666_CR279","doi-asserted-by":"publisher","first-page":"783362","DOI":"10.3389\/fimmu.2021.783362","volume":"12","author":"Z Wu","year":"2014","unstructured":"Wu Z, Lu Z, Li L, Ma M, Long F, Wu R, et al. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer. Front Immunol. 2014;12:783362. https:\/\/doi.org\/10.3389\/fimmu.2021.783362. [cited 2025 Nov 24].","journal-title":"Front Immunol"},{"key":"2666_CR280","doi-asserted-by":"publisher","unstructured":"Chen W, Chen Y, Liu L, Wu Y, Fu P, Cao Y et al. Comprehensive analysis of immune infiltrates of ferroptosis-related long noncoding RNA and prediction of colon cancer patient prognoses. J Immunol Res. 2022;2022:1\u201316. https:\/\/doi.org\/10.1155\/2022\/9480628. Cited 24 Nov 2025.","DOI":"10.1155\/2022\/9480628"},{"key":"2666_CR281","doi-asserted-by":"publisher","first-page":"102225","DOI":"10.1016\/j.ctrv.2021.102225","volume":"98","author":"FJ Crowley","year":"2021","unstructured":"Crowley FJ, O\u2019Cearbhaill RE, Collins DC. Exploiting somatic alterations as therapeutic targets in advanced and metastatic cervical cancer. Cancer Treat Reviews. 2021;98:102225. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102225. [cited 2025 Nov 24].","journal-title":"Cancer Treat Reviews"},{"key":"2666_CR282","doi-asserted-by":"publisher","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD et al. Ovarian cancer statistics, 2018. CA A Cancer J Clinicians. 2018;68:284\u201396. https:\/\/doi.org\/10.3322\/caac.21456.\u00a0Cited 24 Nov 2025.","DOI":"10.3322\/caac.21456"},{"key":"2666_CR283","doi-asserted-by":"publisher","first-page":"888699","DOI":"10.3389\/fonc.2022.888699","volume":"12","author":"K Wang","year":"2022","unstructured":"Wang K, Mei S, Cai M, Zhai D, Zhang D, Yu J, et al. Ferroptosis-Related Long Noncoding RNAs as Prognostic Biomarkers for Ovarian Cancer. Front Oncol. 2022;12:888699. https:\/\/doi.org\/10.3389\/fonc.2022.888699. [cited 2025 Nov 24].","journal-title":"Front Oncol"},{"key":"2666_CR284","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1186\/s12885-022-09805-9","volume":"22","author":"J Hou","year":"2022","unstructured":"Hou J, Lu Z, Cheng X, Dong R, Jiang Y, Wu G, et al. Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer. BMC Cancer. 2022;22:719. https:\/\/doi.org\/10.1186\/s12885-022-09805-9. [cited 2025 Nov 24].","journal-title":"BMC Cancer"},{"key":"2666_CR285","doi-asserted-by":"publisher","unstructured":"Frew IJ, Moch H. A Clearer view of the molecular complexity of clear cell renal cell carcinoma. Annu Rev Pathol Mech Dis. 2015;10:263\u201389. https:\/\/doi.org\/10.1146\/annurev-pathol-012414-040306. Cited 24 Nov 2025.","DOI":"10.1146\/annurev-pathol-012414-040306"},{"key":"2666_CR286","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1186\/s12935-021-02284-1","volume":"21","author":"X-L Xing","year":"2021","unstructured":"Xing X-L, Yao Z-Y, Ou J, Xing C, Li F. Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma. Cancer Cell Int. 2021;21:591. https:\/\/doi.org\/10.1186\/s12935-021-02284-1. [cited 2025 Nov 24].","journal-title":"Cancer Cell Int"},{"key":"2666_CR287","doi-asserted-by":"publisher","unstructured":"Teo MY, Rathkopf DE, Kantoff P. Treatment of advanced prostate cancer. Annu Rev Med. 2019;70:479\u201399. https:\/\/doi.org\/10.1146\/annurev-med-051517-011947. Cited 24 Nov 2025.","DOI":"10.1146\/annurev-med-051517-011947"},{"key":"2666_CR288","doi-asserted-by":"publisher","first-page":"803766","DOI":"10.3389\/fcell.2022.803766","volume":"10","author":"D Feng","year":"2021","unstructured":"Feng D, Shi X, Xiong Q, Zhang F, Li D, Wei W, et al. A Ferroptosis-Related Gene Prognostic Index Associated With Biochemical Recurrence and Radiation Resistance for Patients With Prostate Cancer Undergoing Radical Radiotherapy. Front Cell Dev Biol. 2021;10:803766. https:\/\/doi.org\/10.3389\/fcell.2022.803766. [cited 2025 Nov 24].","journal-title":"Front Cell Dev Biol"},{"key":"2666_CR289","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1056\/NEJMra2034861","volume":"384","author":"BD Curti","year":"2021","unstructured":"Curti BD, Faries MB. Recent Advances in the Treatment of Melanoma. N Engl J Med. 2021;384:2229\u201340. https:\/\/doi.org\/10.1056\/NEJMra2034861. [cited 2025 Nov 24].","journal-title":"N Engl J Med"},{"key":"2666_CR290","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1126\/science.1253735","volume":"346","author":"JA Lo","year":"2014","unstructured":"Lo JA, Fisher DE. The melanoma revolution: From UV carcinogenesis to a new era in therapeutics. Sci. 2014;346:945\u20139. https:\/\/doi.org\/10.1126\/science.1253735. [cited 2025 Nov 24].","journal-title":"Sci"},{"key":"2666_CR291","doi-asserted-by":"publisher","unstructured":"Ma X, Yu S, Zhao B, Bai W, Cui Y, Ni J et al. Development and validation of a novel ferroptosis-related LncRNA signature for predicting prognosis and the immune landscape features in uveal melanoma. Front Immunol. 2023;13:922315. https:\/\/doi.org\/10.3389\/fimmu.2022.922315.\u00a0Cited 24 Nov 2025.","DOI":"10.3389\/fimmu.2022.922315"},{"key":"2666_CR292","doi-asserted-by":"publisher","first-page":"790047","DOI":"10.3389\/fcell.2021.790047","volume":"9","author":"S Sun","year":"2020","unstructured":"Sun S, Zhang G, Zhang L. A Novel Ferroptosis-Related lncRNA Prognostic Model and Immune Infiltration Features in Skin Cutaneous Melanoma. Front Cell Dev Biol. 2020;9:790047. https:\/\/doi.org\/10.3389\/fcell.2021.790047. [cited 2025 Nov 24].","journal-title":"Front Cell Dev Biol"},{"key":"2666_CR293","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra2103423","volume":"385","author":"PS Meltzer","year":"2021","unstructured":"Meltzer PS, Helman LJ. New Horizons in the Treatment of Osteosarcoma. N Engl J Med. 2021;385:2066\u201376. https:\/\/doi.org\/10.1056\/NEJMra2103423. [cited 2025 Nov 24].","journal-title":"N Engl J Med"},{"key":"2666_CR294","doi-asserted-by":"publisher","first-page":"880459","DOI":"10.3389\/fonc.2022.880459","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, He R, Lei X, Mao L, Yin Z, Zhong X, et al. Comprehensive Analysis of a Ferroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Landscape in Osteosarcoma. Front Oncol. 2022;12:880459. https:\/\/doi.org\/10.3389\/fonc.2022.880459. [cited 2025 Nov 24].","journal-title":"Front Oncol"},{"key":"2666_CR295","doi-asserted-by":"publisher","first-page":"816460","DOI":"10.3389\/fgene.2022.816460","volume":"13","author":"S Hong-bin","year":"2022","unstructured":"Hong-bin S, Wan-jun Y, Chen-hui D, Xiao-jie Y, Shen-song L, Peng Z. Identification of an Iron Metabolism-Related lncRNA Signature for Predicting Osteosarcoma Survival and Immune Landscape. Front Genet. 2022;13:816460. https:\/\/doi.org\/10.3389\/fgene.2022.816460. [cited 2025 Nov 24].","journal-title":"Front Genet"},{"key":"2666_CR296","doi-asserted-by":"publisher","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391\u2013405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544.\u00a0Cited 24 Nov 2025.","DOI":"10.1182\/blood-2016-03-643544"},{"key":"2666_CR297","doi-asserted-by":"publisher","unstructured":"Newell LF, Cook RJ. Advances in acute myeloid leukemia. BMJ. 2021;n2026. https:\/\/doi.org\/10.1136\/bmj.n2026. Cited 24 Nov 2025.","DOI":"10.1136\/bmj.n2026"},{"key":"2666_CR298","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1158\/2326-6066.CIR-20-0384","volume":"9","author":"JM Drijvers","year":"2021","unstructured":"Drijvers JM, Gillis JE, Muijlwijk T, Nguyen TH, Gaudiano EF, Harris IS, et al. Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8\u2009+\u2009T Cells. Cancer Immunol Res. 2021;9:184\u201399. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0384. [cited 2025 Nov 24].","journal-title":"Cancer Immunol Res"},{"key":"2666_CR299","doi-asserted-by":"publisher","unstructured":"Xu S, Chaudhary O, Rodr\u00edguez-Morales P, Sun X, Chen D, Zappasodi R et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8\u2009+\u2009T cells in tumors. Immunity. 2021;54:1561\u2013e15777. https:\/\/doi.org\/10.1016\/j.immuni.2021.05.003.\u00a0Cited 24 Nov 2025.","DOI":"10.1016\/j.immuni.2021.05.003"},{"key":"2666_CR300","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma X, Xiao L, Liu L, Ye L, Su P, Bi E, et al. CD36-mediated ferroptosis dampens intratumoral CD8\u2009+\u2009T cell effector function and impairs their antitumor ability. Cell Metabolism. 2021;33:1001\u2013e10125. https:\/\/doi.org\/10.1016\/j.cmet.2021.02.015. [cited 2025 Nov 24].","journal-title":"Cell Metabolism"},{"key":"2666_CR301","doi-asserted-by":"publisher","first-page":"109235","DOI":"10.1016\/j.celrep.2021.109235","volume":"35","author":"C Xu","year":"2021","unstructured":"Xu C, Sun S, Johnson T, Qi R, Zhang S, Zhang J, et al. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity. Cell Rep. 2021;35:109235. https:\/\/doi.org\/10.1016\/j.celrep.2021.109235. [cited 2025 Nov 24].","journal-title":"Cell Rep"},{"key":"2666_CR302","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","volume":"16","author":"AA Kapralov","year":"2020","unstructured":"Kapralov AA, Yang Q, Dar HH, Tyurina YY, Anthonymuthu TS, Kim R, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat Chem Biol. 2020;16:278\u201390. https:\/\/doi.org\/10.1038\/s41589-019-0462-8. [cited 2025 Nov 24].","journal-title":"Nat Chem Biol"},{"key":"2666_CR303","doi-asserted-by":"publisher","first-page":"42791","DOI":"10.1021\/acsami.2c00707","volume":"14","author":"C Wu","year":"2022","unstructured":"Wu C, Shen Z, Lu Y, Sun F, Shi H. p53 Promotes Ferroptosis in Macrophages Treated with Fe3O4 Nanoparticles. ACS Appl Mater Interfaces. 2022;14:42791\u2013803. https:\/\/doi.org\/10.1021\/acsami.2c00707. [cited 2025 Nov 24].","journal-title":"ACS Appl Mater Interfaces"},{"key":"2666_CR304","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","volume":"612","author":"R Kim","year":"2022","unstructured":"Kim R, Hashimoto A, Markosyan N, Tyurin VA, Tyurina YY, Kar G, et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nat. 2022;612:338\u201346. https:\/\/doi.org\/10.1038\/s41586-022-05443-0. [cited 2025 Nov 24].","journal-title":"Nat"},{"key":"2666_CR305","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.4049\/jimmunol.2000500","volume":"206","author":"H Zhu","year":"2021","unstructured":"Zhu H, Klement JD, Lu C, Redd PS, Yang D, Smith AD, et al. Asah2 Represses the p53\u2013Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis. J Immunol. 2021;206:1395\u2013404. https:\/\/doi.org\/10.4049\/jimmunol.2000500. [cited 2025 Nov 24].","journal-title":"J Immunol"},{"key":"2666_CR306","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/s41418-020-00719-2","volume":"28","author":"X Luo","year":"2021","unstructured":"Luo X, Gong H-B, Gao H-Y, Wu Y-P, Sun W-Y, Li Z-Q, et al. Oxygenated phosphatidylethanolamine navigates phagocytosis of ferroptotic cells by interacting with TLR2. Cell Death Differ. 2021;28:1971\u201389. https:\/\/doi.org\/10.1038\/s41418-020-00719-2. [cited 2025 Nov 24].","journal-title":"Cell Death Differ"},{"key":"2666_CR307","doi-asserted-by":"publisher","unstructured":"Wen Q, Liu J, Kang R, Zhou B, Tang D. The release and activity of HMGB1 in ferroptosis. Biochem Biophys Res Commun. 2019;510:278\u201383. https:\/\/doi.org\/10.1016\/j.bbrc.2019.01.090. Cited 24 Nov 2025.","DOI":"10.1016\/j.bbrc.2019.01.090"},{"key":"2666_CR308","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1002\/jcp.30125","volume":"236","author":"J Xue","year":"2021","unstructured":"Xue J, Suarez JS, Minaai M, Li S, Gaudino G, Pass HI, et al. HMGB1 as a therapeutic target in disease. J Cell Physiol. 2021;236:3406\u201319. https:\/\/doi.org\/10.1002\/jcp.30125. [cited 2025 Nov 24].","journal-title":"J Cell Physiol"},{"key":"2666_CR309","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1038\/s41467-020-17380-5","volume":"11","author":"B Yu","year":"2020","unstructured":"Yu B, Choi B, Li W, Kim D-H. Magnetic field boosted ferroptosis-like cell death and responsive MRI using hybrid vesicles for cancer immunotherapy. Nat Commun. 2020;11:3637. https:\/\/doi.org\/10.1038\/s41467-020-17380-5. [cited 2025 Nov 24].","journal-title":"Nat Commun"},{"key":"2666_CR310","doi-asserted-by":"publisher","first-page":"2300881","DOI":"10.1002\/advs.202300881","volume":"10","author":"F Jiang","year":"2023","unstructured":"Jiang F, Jia K, Chen Y, Ji C, Chong X, Li Z, et al. ANO1-Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer\u2010Associated Fibroblasts. Adv Sci. 2023;10:2300881. https:\/\/doi.org\/10.1002\/advs.202300881. [cited 2025 Nov 24].","journal-title":"Adv Sci"},{"key":"2666_CR311","doi-asserted-by":"publisher","unstructured":"Dai E, Han L, Liu J, Xie Y, Kroemer G, Klionsky DJ et al. Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein. Autophagy. 2020;16:2069\u201383. https:\/\/doi.org\/10.1080\/15548627.2020.1714209. Cited 24 Nov 2025.","DOI":"10.1080\/15548627.2020.1714209"},{"key":"2666_CR312","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1038\/s41467-020-20154-8","volume":"11","author":"E Dai","year":"2020","unstructured":"Dai E, Han L, Liu J, Xie Y, Zeh HJ, Kang R, et al. Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173\/STING-dependent DNA sensor pathway. Nat Commun. 2020;11:6339. https:\/\/doi.org\/10.1038\/s41467-020-20154-8. [cited 2025 Nov 24].","journal-title":"Nat Commun"},{"key":"2666_CR313","doi-asserted-by":"publisher","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Sig Transduct Target Ther. 2024;9:55. https:\/\/doi.org\/10.1038\/s41392-024-01769-5.\u00a0Cited 24 Nov 2025.","DOI":"10.1038\/s41392-024-01769-5"},{"key":"2666_CR314","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1016\/j.apsb.2023.03.025","volume":"13","author":"Y Luo","year":"2023","unstructured":"Luo Y, Chen Y, Jin H, Hou B, Li H, Li X, et al. The suppression of cervical cancer ferroptosis by macrophages: The attenuation of ALOX15 in cancer cells by macrophages-derived exosomes. Acta Pharm Sinica B. 2023;13:2645\u201362. https:\/\/doi.org\/10.1016\/j.apsb.2023.03.025. [cited 2025 Nov 24].","journal-title":"Acta Pharm Sinica B"},{"key":"2666_CR315","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.21037\/tcr-22-96","volume":"11","author":"Z Hu","year":"2022","unstructured":"Hu Z, Zhang H, Liu W, Yin Y, Jiang J, Yan C, et al. Mechanism of HBV-positive liver cancer cell exosomal miR-142-3p by inducing ferroptosis of M1 macrophages to promote liver cancer progression. Transl Cancer Res TCR. 2022;11:1173\u201387. https:\/\/doi.org\/10.21037\/tcr-22-96. [cited 2025 Nov 24].","journal-title":"Transl Cancer Res TCR"},{"key":"2666_CR316","doi-asserted-by":"publisher","unstructured":"Xiao H, Du X, Tao Z, Jing N, Bao S, Gao W et al. Taurine inhibits ferroptosis mediated by the crosstalk between tumor cells and tumor-associated macrophages in prostate cancer. Adv Sci. 2024;11:2303894. https:\/\/doi.org\/10.1002\/advs.202303894. Cited 24 Nov 2025.","DOI":"10.1002\/advs.202303894"},{"key":"2666_CR317","doi-asserted-by":"publisher","first-page":"797339","DOI":"10.3389\/fcell.2021.797339","volume":"9","author":"F Yao","year":"2021","unstructured":"Yao F, Zhan Y, Pu Z, Lu Y, Chen J, Deng J, et al. LncRNAs Target Ferroptosis-Related Genes and Impair Activation of CD4\u2009+\u2009T Cell in Gastric Cancer. Front Cell Dev Biol. 2021;9:797339. https:\/\/doi.org\/10.3389\/fcell.2021.797339. [cited 2025 Nov 24].","journal-title":"Front Cell Dev Biol"},{"key":"2666_CR318","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/anie.202012237","volume":"60","author":"X Luo","year":"2021","unstructured":"Luo X, Gong X, Su L, Lin H, Yang Z, Yan X, et al. Activatable Mitochondria-Targeting Organoarsenic Prodrugs for Bioenergetic Cancer Therapy. Angew Chem Int Ed. 2021;60:1403\u201310. https:\/\/doi.org\/10.1002\/anie.202012237. [cited 2025 Nov 24].","journal-title":"Angew Chem Int Ed"},{"key":"2666_CR319","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP\u2013dependent transporters. Nat Rev Cancer. 2002;2:48\u201358. https:\/\/doi.org\/10.1038\/nrc706. [cited 2025 Nov 24].","journal-title":"Nat Rev Cancer"},{"key":"2666_CR320","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13:91\u20138. https:\/\/doi.org\/10.1038\/nchembio.2239. [cited 2025 Nov 24].","journal-title":"Nat Chem Biol"},{"key":"2666_CR321","doi-asserted-by":"publisher","first-page":"103200","DOI":"10.1016\/j.redox.2024.103200","volume":"73","author":"X Mao","year":"2024","unstructured":"Mao X, Xu J, Xiao M, Liang C, Hua J, Liu J, et al. ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis. Redox Biology. 2024;73:103200. https:\/\/doi.org\/10.1016\/j.redox.2024.103200. [cited 2025 Nov 24].","journal-title":"Redox Biology"},{"key":"2666_CR322","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.neo.2021.11.002","volume":"23","author":"W Huang","year":"2021","unstructured":"Huang W, Chen K, Lu Y, Zhang D, Cheng Y, Li L, et al. ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma. Neoplasia. 2021;23:1227\u201339. https:\/\/doi.org\/10.1016\/j.neo.2021.11.002. [cited 2025 Nov 24].","journal-title":"Neoplasia"},{"key":"2666_CR323","doi-asserted-by":"publisher","first-page":"102952","DOI":"10.1016\/j.redox.2023.102952","volume":"68","author":"Z Xu","year":"2023","unstructured":"Xu Z, Wang X, Sun W, Xu F, Kou H, Hu W, et al. RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer. Redox Biology. 2023;68:102952. https:\/\/doi.org\/10.1016\/j.redox.2023.102952. [cited 2025 Nov 24].","journal-title":"Redox Biology"},{"key":"2666_CR324","doi-asserted-by":"publisher","first-page":"105450","DOI":"10.1016\/j.ejps.2020.105450","volume":"152","author":"X Xu","year":"2020","unstructured":"Xu X, Zhang X, Wei C, Zheng D, Lu X, Yang Y, et al. Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis. Eur J Pharm Sci. 2020;152:105450. https:\/\/doi.org\/10.1016\/j.ejps.2020.105450. [cited 2025 Nov 24].","journal-title":"Eur J Pharm Sci"},{"key":"2666_CR325","doi-asserted-by":"publisher","first-page":"1904197","DOI":"10.1002\/adma.201904197","volume":"31","author":"C Liang","year":"2019","unstructured":"Liang C, Zhang X, Yang M, Dong X. Recent Progress in Ferroptosis Inducers for Cancer Therapy. Adv Mater. 2019;31:1904197. https:\/\/doi.org\/10.1002\/adma.201904197. [cited 2025 Nov 24].","journal-title":"Adv Mater"},{"key":"2666_CR326","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jconrel.2020.01.008","volume":"319","author":"X Shan","year":"2020","unstructured":"Shan X, Li S, Sun B, Chen Q, Sun J, He Z, et al. Ferroptosis-driven nanotherapeutics for cancer treatment. J Controlled Release. 2020;319:322\u201332. https:\/\/doi.org\/10.1016\/j.jconrel.2020.01.008. [cited 2025 Nov 24].","journal-title":"J Controlled Release"},{"key":"2666_CR327","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41568-025-00864-1","volume":"25","author":"A Wahida","year":"2025","unstructured":"Wahida A, Conrad M. Decoding ferroptosis for cancer therapy. Nat Rev Cancer. 2025;25:910\u201324. https:\/\/doi.org\/10.1038\/s41568-025-00864-1.","journal-title":"Nat Rev Cancer"},{"key":"2666_CR328","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41589-018-0031-6","volume":"14","author":"MM Gaschler","year":"2018","unstructured":"Gaschler MM, Andia AA, Liu H, Csuka JM, Hurlocker B, Vaiana CA, et al. FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat Chem Biol. 2018;14:507\u201315. https:\/\/doi.org\/10.1038\/s41589-018-0031-6.","journal-title":"Nat Chem Biol"},{"key":"2666_CR329","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41420-022-01297-7","volume":"8","author":"Y Du","year":"2022","unstructured":"Du Y, Guo Z. Recent progress in ferroptosis: inducers and inhibitors. Cell Death Discov. 2022;8:501. https:\/\/doi.org\/10.1038\/s41420-022-01297-7.","journal-title":"Cell Death Discov"},{"key":"2666_CR330","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.chembiol.2024.10.014","volume":"31","author":"M Wang","year":"2024","unstructured":"Wang M, Prachyathipsakul T, Silva CA, Xiong C, Goel S, Goel HL, et al. Therapeutic induction of ferroptosis in tumors using PD-L1 targeting antibody nanogel conjugates. Cell Chem Biol. 2024;31:2039\u201351. https:\/\/doi.org\/10.1016\/j.chembiol.2024.10.014. .e6.","journal-title":"Cell Chem Biol"},{"key":"2666_CR331","doi-asserted-by":"publisher","first-page":"681223","DOI":"10.3389\/fphar.2021.681223","volume":"12","author":"D Sun","year":"2023","unstructured":"Sun D, Li Y-C, Zhang X-Y. Lidocaine Promoted Ferroptosis by Targeting miR-382-5p \/SLC7A11 Axis in Ovarian and Breast Cancer. Front Pharmacol. 2023;12:681223. https:\/\/doi.org\/10.3389\/fphar.2021.681223. [cited 2025 Nov 24].","journal-title":"Front Pharmacol"},{"key":"2666_CR332","doi-asserted-by":"publisher","unstructured":"Sun Y, Qiao Y, Liu Y, Zhou J, Wang X, Zheng H et al. ent-Kaurane diterpenoids induce apoptosis and ferroptosis through targeting redox resetting to overcome cisplatin resistance. Redox Biology. 2021;43:101977. https:\/\/doi.org\/10.1016\/j.redox.2021.101977. Cited 24 Nov 2025.","DOI":"10.1016\/j.redox.2021.101977"},{"key":"2666_CR333","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.canlet.2016.07.035","volume":"381","author":"J-L Roh","year":"2016","unstructured":"Roh J-L, Kim EH, Jang HJ, Park JY, Shin D. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer. Cancer Lett. 2016;381:96\u2013103. https:\/\/doi.org\/10.1016\/j.canlet.2016.07.035. [cited 2025 Nov 24].","journal-title":"Cancer Lett"},{"key":"2666_CR334","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41419-021-03996-y","volume":"12","author":"J Du","year":"2024","unstructured":"Du J, Wang X, Li Y, Ren X, Zhou Y, Hu W, et al. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism. Cell Death Dis. 2024;12:705. https:\/\/doi.org\/10.1038\/s41419-021-03996-y. [cited 2025 Nov 24].","journal-title":"Cell Death Dis"},{"key":"2666_CR335","doi-asserted-by":"publisher","unstructured":"Chen T-C, Chuang J-Y, Ko C-Y, Kao T-J, Yang P-Y, Yu C-H et al. AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis. Redox Biology. 2020;30:101413. https:\/\/doi.org\/10.1016\/j.redox.2019.101413. Cited 24 Nov 2025.","DOI":"10.1016\/j.redox.2019.101413"},{"key":"2666_CR336","doi-asserted-by":"publisher","unstructured":"Yang C, Chen Z, Wei M, Hu S, Cai M, Wang N et al. A self-amplified ferroptosis nanoagent that inhibits the tumor upstream glutathione synthesis to reverse cancer chemoresistance. J Controlled Release. 2023;357:20\u201330. https:\/\/doi.org\/10.1016\/j.jconrel.2023.03.030. Cited 24 Nov 2025.","DOI":"10.1016\/j.jconrel.2023.03.030"},{"key":"2666_CR337","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21:47. https:\/\/doi.org\/10.1186\/s12943-022-01530-y. [cited 2025 Nov 24].","journal-title":"Mol Cancer"},{"key":"2666_CR338","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42:513\u201334. https:\/\/doi.org\/10.1016\/j.ccell.2024.03.011. [cited 2025 Nov 24].","journal-title":"Cancer Cell"},{"key":"2666_CR339","doi-asserted-by":"publisher","first-page":"2300824","DOI":"10.1002\/advs.202300824","volume":"10","author":"X Zhu","year":"2023","unstructured":"Zhu X, Li S, Ferroptosis, Necroptosis, Pyroptosis in Gastrointestinal Cancers. The Chief Culprits of Tumor Progression and Drug Resistance. Adv Sci. 2023;10:2300824. https:\/\/doi.org\/10.1002\/advs.202300824. [cited 2025 Nov 24].","journal-title":"Adv Sci"},{"key":"2666_CR340","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.freeradbiomed.2025.09.002","volume":"240","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Liu W, Deng K, Chen Y, Zhou P, Liu C, et al. LncRNA BASP1-AS1 drives PCBP2 K115 lactylation to suppress ferroptosis and confer oxaliplatin resistance in gastric cancer. Free Radical Biology Med. 2025;240:717\u201334. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.09.002.","journal-title":"Free Radical Biology Med"},{"key":"2666_CR341","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12967-025-06128-8","volume":"23","author":"B Xie","year":"2025","unstructured":"Xie B, Wu P, Liu H, Yang X, Huang L. Long non-coding RNA MIR4435-2HG modulates pancreatic cancer stem cells and chemosensitivity to gemcitabine by targeting the miR-1252-5p\/STAT1. J Transl Med. 2025;23:165. https:\/\/doi.org\/10.1186\/s12967-025-06128-8.","journal-title":"J Transl Med"},{"key":"2666_CR342","doi-asserted-by":"publisher","first-page":"113804","DOI":"10.1016\/j.intimp.2024.113804","volume":"146","author":"H Han","year":"2025","unstructured":"Han H, Li Y, Lin Z, Ma X, Huang W, Lu C, et al. Exosomal miR-130a-3p confers cisplatin resistance in esophageal cancer by regulating ferroptosis via the suppression of METTL14-mediated m6A RNA methylation of FSP1. Int Immunopharmacol. 2025;146:113804. https:\/\/doi.org\/10.1016\/j.intimp.2024.113804.","journal-title":"Int Immunopharmacol"},{"key":"2666_CR343","doi-asserted-by":"publisher","first-page":"e01042","DOI":"10.1002\/advs.202501042","volume":"12","author":"Z Chen","year":"2025","unstructured":"Chen Z, Shan J, Chen M, Wu Z, Zhao Y, Zhu H, et al. Targeting GPX4 to Induce Ferroptosis Overcomes Chemoresistance Mediated by the PAX8-AS1 \/GPX4 Axis in Intrahepatic Cholangiocarcinoma. Adv Sci. 2025;12:e01042. https:\/\/doi.org\/10.1002\/advs.202501042.","journal-title":"Adv Sci"},{"key":"2666_CR344","doi-asserted-by":"publisher","first-page":"104305","DOI":"10.3748\/wjg.v31.i16.104305","volume":"31","author":"Q Dai","year":"2025","unstructured":"Dai Q, Qu T-Y, Yang J-L, Leng J, Fang L, Zhu Q-Q, et al. LncRNA FTX promotes colorectal cancer radioresistance through disturbing redox balance and inhibiting ferroptosis via miR-625-5p\/SCL7A11 axis. World J Gastroenterol. 2025;31:104305. https:\/\/doi.org\/10.3748\/wjg.v31.i16.104305.","journal-title":"World J Gastroenterol"},{"key":"2666_CR345","doi-asserted-by":"publisher","first-page":"101181","DOI":"10.1016\/j.drup.2024.101181","volume":"78","author":"C-J Shi","year":"2025","unstructured":"Shi C-J, Pang F-X, Lei Y-H, Deng L-Q, Pan F-Z, Liang Z-Q, et al. 5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1\/SLC7A11-mediated ferroptosis. Drug Resist Updates. 2025;78:101181. https:\/\/doi.org\/10.1016\/j.drup.2024.101181.","journal-title":"Drug Resist Updates"},{"key":"2666_CR346","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.7150\/thno.99197","volume":"14","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Han S, Zeng Z, Zheng H, Li Y, Wang F, et al. Decreased lncRNA HNF4A-AS1 facilitates resistance to sorafenib-induced ferroptosis of hepatocellular carcinoma by reprogramming lipid metabolism. Theranostics. 2024;14:7088\u2013110. https:\/\/doi.org\/10.7150\/thno.99197.","journal-title":"Theranostics"},{"key":"2666_CR347","doi-asserted-by":"publisher","first-page":"e70488","DOI":"10.1002\/mco2.70488","volume":"6","author":"L Ji","year":"2025","unstructured":"Ji L, Ruan Y, Tong M, Chen T, Cai J, Ye Z, et al. circRNA-SORE\/UBQLN1\/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis. MedComm. 2025;6:e70488. https:\/\/doi.org\/10.1002\/mco2.70488.","journal-title":"MedComm"},{"key":"2666_CR348","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-024-02224-3","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Yao R, Li M, Fang C, Feng K, Chen X, et al. CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p\/SLC7A11 axis. Mol Cancer. 2025;24:32. https:\/\/doi.org\/10.1186\/s12943-024-02224-3.","journal-title":"Mol Cancer"},{"key":"2666_CR349","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41419-025-07456-9","volume":"16","author":"Y Pan","year":"2025","unstructured":"Pan Y, Liu S, Shu G, Chen M, Fu L, Chen C, et al. STX17-DT facilitates axitinib resistance in renal cell carcinoma by inhibiting mitochondrial ROS accumulation and ferroptosis. Cell Death Dis. 2025;16:125. https:\/\/doi.org\/10.1038\/s41419-025-07456-9.","journal-title":"Cell Death Dis"},{"key":"2666_CR350","doi-asserted-by":"publisher","first-page":"101240","DOI":"10.1016\/j.drup.2025.101240","volume":"81","author":"H Lin","year":"2025","unstructured":"Lin H, Zhu S, Chen Y, Lu J, Xie C, Liao C, et al. Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. Drug Resist Updates. 2025;81:101240. https:\/\/doi.org\/10.1016\/j.drup.2025.101240.","journal-title":"Drug Resist Updates"},{"key":"2666_CR351","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41580-025-00843-2","volume":"26","author":"E Mishima","year":"2025","unstructured":"Mishima E, Nakamura T, Doll S, Proneth B, Fedorova M, Pratt DA, et al. Recommendations for robust and reproducible research on ferroptosis. Nat Rev Mol Cell Biol. 2025;26:615\u201330. https:\/\/doi.org\/10.1038\/s41580-025-00843-2.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2666_CR352","doi-asserted-by":"publisher","first-page":"e006516","DOI":"10.1136\/jitc-2022-006516","volume":"11","author":"D Wang","year":"2023","unstructured":"Wang D, Qiu G, Zhu X, Wang Q, Zhu C, Fang C, et al. Macrophage-inherited exosome excise tumor immunosuppression to expedite immune-activated ferroptosis. J Immunother Cancer. 2023;11:e006516. https:\/\/doi.org\/10.1136\/jitc-2022-006516. [cited 2025 Nov 24].","journal-title":"J Immunother Cancer"},{"key":"2666_CR353","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/cancers16010155","volume":"16","author":"C Desterke","year":"2023","unstructured":"Desterke C, Xiang Y, Elhage R, Duruel C, Chang Y, Hama\u00ef A. Ferroptosis Inducers Upregulate PD-L1 in Recurrent Triple-Negative Breast Cancer. Cancers (Basel). 2023;16:155. https:\/\/doi.org\/10.3390\/cancers16010155.","journal-title":"Cancers (Basel)"},{"key":"2666_CR354","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12951-022-01635-y","volume":"20","author":"K-S Kim","year":"2022","unstructured":"Kim K-S, Choi B, Choi H, Ko MJ, Kim D-H, Kim D-H. Enhanced natural killer cell anti-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer. J Nanobiotechnol. 2022;20:428. https:\/\/doi.org\/10.1186\/s12951-022-01635-y.","journal-title":"J Nanobiotechnol"},{"key":"2666_CR355","doi-asserted-by":"publisher","first-page":"1208485","DOI":"10.3389\/fcell.2023.1208485","volume":"11","author":"AM Battaglia","year":"2023","unstructured":"Battaglia AM, Sacco A, Aversa I, Santamaria G, Palmieri C, Botta C, et al. Iron-mediated oxidative stress induces PD-L1 expression via activation of c-Myc in lung adenocarcinoma. Front Cell Dev Biol. 2023;11:1208485. https:\/\/doi.org\/10.3389\/fcell.2023.1208485.","journal-title":"Front Cell Dev Biol"},{"key":"2666_CR356","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13046-025-03593-3","volume":"45","author":"M Caforio","year":"2025","unstructured":"Caforio M, Iacovelli S, Locatelli F, Folgiero V. Inducing ferroptosis to improve cancer therapy: a promising tool for enhancing immunotherapy. J Exp Clin Cancer Res. 2025;45:10. https:\/\/doi.org\/10.1186\/s13046-025-03593-3.","journal-title":"J Exp Clin Cancer Res"},{"key":"2666_CR357","doi-asserted-by":"publisher","first-page":"0009","DOI":"10.34133\/cancomm.0009","volume":"46","author":"C Hu","year":"2026","unstructured":"Hu C, Hu F, Shao C, He Y, Su L, Shi D, et al. TIMELESS Promotes LUAD Growth via Suppressing Transferrin-Mediated Ferroptosis and Reprograms the Tumor Microenvironment against Anti-PD-1 Immunotherapy. Cancer Commun (Lond) Lond Engl. 2026;46:0009. https:\/\/doi.org\/10.34133\/cancomm.0009.","journal-title":"Cancer Commun (Lond) Lond Engl"},{"key":"2666_CR358","doi-asserted-by":"publisher","first-page":"104055","DOI":"10.1016\/j.redox.2026.104055","volume":"90","author":"W Zhu","year":"2026","unstructured":"Zhu W, Qi H, Jing F, Shi Y, Xing Y, Ma X, et al. DMNQ induces ferroptosis and augments the efficacy of anti-PD-L1 immunotherapy in gastric cancer via the STAT3\/SLC1A4 axis to mediate cysteine metabolism reprogramming. Redox Biol. 2026;90:104055. https:\/\/doi.org\/10.1016\/j.redox.2026.104055.","journal-title":"Redox Biol"},{"key":"2666_CR359","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-021-01396-6","volume":"20","author":"X-H Tang","year":"2021","unstructured":"Tang X-H, Guo T, Gao X-Y, Wu X-L, Xing X-F, Ji J-F, et al. Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications. Mol Cancer. 2021;20:99. https:\/\/doi.org\/10.1186\/s12943-021-01396-6. [cited 2025 Nov 24].","journal-title":"Mol Cancer"},{"key":"2666_CR360","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics \u2014 challenges and potential solutions. Nat Rev Drug Discov. 2021;20:629\u201351. https:\/\/doi.org\/10.1038\/s41573-021-00219-z. [cited 2025 Nov 24].","journal-title":"Nat Rev Drug Discov"},{"key":"2666_CR361","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203\u201322. https:\/\/doi.org\/10.1038\/nrd.2016.246. [cited 2025 Nov 24].","journal-title":"Nat Rev Drug Discov"},{"key":"2666_CR362","doi-asserted-by":"publisher","first-page":"101908","DOI":"10.1016\/j.redox.2021.101908","volume":"42","author":"Y Luo","year":"2021","unstructured":"Luo Y, Niu G, Yi H, Li Q, Wu Z, Wang J, et al. Nanomedicine promotes ferroptosis to inhibit tumour proliferation in vivo. Redox Biology. 2021;42:101908. https:\/\/doi.org\/10.1016\/j.redox.2021.101908. [cited 2025 Nov 24].","journal-title":"Redox Biology"},{"key":"2666_CR363","doi-asserted-by":"publisher","unstructured":"Xu X, Ho W, Zhang X, Bertrand N, Farokhzad O. Cancer nanomedicine: from targeted delivery to combination therapy. Trends in Molecular Medicine. 2015;21:223\u201332. https:\/\/doi.org\/10.1016\/j.molmed.2015.01.001. Cited 24 Nov 2025.","DOI":"10.1016\/j.molmed.2015.01.001"},{"key":"2666_CR364","doi-asserted-by":"publisher","unstructured":"Feldman EJ, Lancet JE, Kolitz JE, Ritchie EK, Roboz GJ, List AF et al. First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia. JCO. 2011;29:979\u201385. https:\/\/doi.org\/10.1200\/JCO.2010.30.5961.\u00a0Cited 24 Nov 2025.","DOI":"10.1200\/JCO.2010.30.5961"},{"key":"2666_CR365","doi-asserted-by":"publisher","unstructured":"Su Y, Liu B, Wang B, Chan L, Xiong C, Lu L et al. Progress and challenges in tumor ferroptosis treatment strategies: a comprehensive review of metal complexes and nanomedicine. Small. 2024;20:2310342. https:\/\/doi.org\/10.1002\/smll.202310342. Cited 24 Nov 2025.","DOI":"10.1002\/smll.202310342"},{"key":"2666_CR366","doi-asserted-by":"publisher","unstructured":"Yang H, Yao X, Liu Y, Shen X, Li M, Luo Z. Ferroptosis nanomedicine: clinical challenges and opportunities for modulating tumor metabolic and immunological landscape. ACS Nano. 2023;17:15328\u201353. https:\/\/doi.org\/10.1021\/acsnano.3c04632.\u00a0Cited 24 Nov 2025.","DOI":"10.1021\/acsnano.3c04632"},{"key":"2666_CR367","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1021\/acs.molpharmaceut.3c01040","volume":"21","author":"R Pandey","year":"2024","unstructured":"Pandey R, Chiu C-C, Wang L-F. Immunotherapy Study on Non-small-Cell Lung Cancer (NSCLC) Combined with Cytotoxic T Cells and miRNA34a. Mol Pharm. 2024;21:1364\u201381. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c01040. [cited 2025 Nov 24].","journal-title":"Mol Pharm"},{"key":"2666_CR368","doi-asserted-by":"publisher","first-page":"9937","DOI":"10.7150\/thno.65480","volume":"11","author":"L Luo","year":"2021","unstructured":"Luo L, Wang H, Tian W, Li X, Zhu Z, Huang R, et al. Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications. Theranostics. 2021;11:9937\u201352. https:\/\/doi.org\/10.7150\/thno.65480. [cited 2025 Nov 24].","journal-title":"Theranostics"},{"key":"2666_CR369","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.tips.2023.07.007","volume":"44","author":"SK Ryan","year":"2023","unstructured":"Ryan SK, Ugalde CL, Rolland A-S, Skidmore J, Devos D, Hammond TR. Therapeutic inhibition of ferroptosis in neurodegenerative disease. Trends Pharmacol Sci. 2023;44:674\u201388. https:\/\/doi.org\/10.1016\/j.tips.2023.07.007.","journal-title":"Trends Pharmacol Sci"},{"key":"2666_CR370","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41413-023-00247-y","volume":"11","author":"Q Ru","year":"2023","unstructured":"Ru Q, Li Y, Xie W, Ding Y, Chen L, Xu G, et al. Fighting age-related orthopedic diseases: focusing on ferroptosis. Bone Res. 2023;11:12. https:\/\/doi.org\/10.1038\/s41413-023-00247-y.","journal-title":"Bone Res"},{"key":"2666_CR371","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J, Wang F, Min J. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther. 2023;8:372. https:\/\/doi.org\/10.1038\/s41392-023-01606-1.","journal-title":"Signal Transduct Target Ther"},{"key":"2666_CR372","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-022-01615-8","volume":"21","author":"Y Xi","year":"2022","unstructured":"Xi Y, Shen Y, Wu D, Zhang J, Lin C, Wang L, et al. CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p. Mol Cancer. 2022;21:145. https:\/\/doi.org\/10.1186\/s12943-022-01615-8.","journal-title":"Mol Cancer"},{"key":"2666_CR373","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s10495-026-02279-1","volume":"31","author":"D Madappan","year":"2026","unstructured":"Madappan D, Krishnegowda MB, Naik P, Raju DB, Hadapada L, Sriramareddy Y, et al. Ferroptosis-centered strategies: redefining therapeutic resistance & adaptation in modern oncology. Apoptosis. 2026;31:62. https:\/\/doi.org\/10.1007\/s10495-026-02279-1.","journal-title":"Apoptosis"},{"key":"2666_CR374","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s12672-024-01573-1","volume":"15","author":"C Gao","year":"2024","unstructured":"Gao C, Zhang H, Wang X. Current advances on the role of ferroptosis in tumor immune evasion. Discov Oncol. 2024;15:736. https:\/\/doi.org\/10.1007\/s12672-024-01573-1.","journal-title":"Discov Oncol"},{"key":"2666_CR375","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.semcancer.2020.12.006","volume":"83","author":"P Mondal","year":"2022","unstructured":"Mondal P, Natesh J, Penta D, Meeran SM. Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update. Seminars Cancer Biology. 2022;83:503\u201322. https:\/\/doi.org\/10.1016\/j.semcancer.2020.12.006. [cited 2025 Nov 24].","journal-title":"Seminars Cancer Biology"},{"key":"2666_CR376","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","volume":"7","author":"B Chen","year":"2024","unstructured":"Chen B, Dragomir MP, Yang C, Li Q, Horst D, Calin GA. Targeting non-coding RNAs to overcome cancer therapy resistance. Sig Transduct Target Ther. 2024;7:121. https:\/\/doi.org\/10.1038\/s41392-022-00975-3. [cited 2025 Nov 24].","journal-title":"Sig Transduct Target Ther"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02666-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02666-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02666-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:07:49Z","timestamp":1782781669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02666-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":376,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2666"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02666-x","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed on the contents of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}